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ABSTRACT

Proteins are the building blocks of cells in living organisms, and are composed of
amino acids. The expression of proteins is regulated by the processes of transcription and
translation. Proteins undergo post-translational modifications in order to dictate their role
physiologically within a cell.
Not all post-translational modifications are beneficial for the protein or the cell.
One type o f post-translational modification, called carbonylation, irreversibly places a
carbonyl group onto an amino acid residue, most commonly proline, lysine, arginine, and
threonine. This modification can have severe consequences physiologically, including
loss of solubility, loss o f function, and protein aggregation.
Carbonylated proteins have commonly been used as a marker o f oxidative stress.
Oxidative stress has been suggested to play a role in many human disease states, such as
Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Parkinson’s Disease, inflammatory
diseases, and others. Evidence shows oxidative stress to be a contributing factor in the
progression of aging. Therefore, markers o f oxidative stress, such as carbonylated
proteins, can provide key information for the development o f valuable therapeutics for
these conditions. However, they are found in low abundance in samples and require
enrichment prior to proteomic-based studies.
Currently, affinity chromatography is the chosen method for enriching
carbonylated proteins in a sample. However, the technique has significant drawbacks,

including a large sample requirement, a large time requirement, the need for
derivatization, and a high dilution of the sample post elution. This dissertation introduces
a microfluidic enrichment technique for carbonylated proteins. The technique involves
the surface modification o f a polymer microchip for selective capture o f carbonylated
proteins. The surface chemistry is verified using different analytical techniques.
Specificity of the target molecule’s capture is demonstrated using a native protein. The
capture conditions are optimized experimentally by studying four unique variables.
Lastly, theoretical modeling is performed to determine the conditions that would lead to
the technique’s failure. It is seen that the technique can selectively capture target proteins
from a flowing solution, even in the presence of an unoxidized protein. Protein capture is
most dependent upon flow rate and crosslinker concentration. The flow rates required to
break the bonds formed between an oxidized protein and the crosslinker exceeds feasible
levels within a microfluidic channel. The microfluidic enrichment technique provides a
promising alternative to the current “gold standard” of avidin affinity chromatography.
The device has promise as a possible protein biomarker discovery tool in the search for
therapeutic targets in human disease states where oxidative stress has been implicated.
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CHAPTER 1

INTRODUCTION

1.1

Proteins

Proteins are key components o f cells (Vogel, 2011). They serve numerous
physiological functions, including regulatory activities, enzymatic activity, and structural
purposes. They are considered an important part of the diet; if there are too few proteins
in their nutritional intake, humans can become very ill. Proteins can also serve as toxic
agents. A few examples o f these would be Botulinum toxin A and ricin, some of the
most potent known toxins.
Proteins are also called polypeptides because their structure resembles a polymer
chain of peptides. Peptides are small chains of amino acids connected by a peptide bond.
These molecules are typically less than 10 kDa in molecular weight. The building blocks
of peptides are amino acids, small organic molecules that form the backbone o f proteins
(Lusk, 1910). Protein synthesis occurs inside the cell, and their expression is regulated
by DNA and RNA in processes called transcription and translation. Following the
translation process, proteins are further modified through processes called posttranslational modifications that are often used as signaling mechanisms for what the
protein’s function will be, along with where in the cell the protein will be permanently
located.
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1.1.1

Amino Acids Are the Building Blocks o f Proteins
There are over 300 naturally occurring amino acids; however, proteins are usually

composed of 20 a-amino acids (Uddin et al., 2012). The amino acids share a common
structure; they have an anime group (-NH 2 ) linked to an a-carbon atom, which is attached
to a carboxylic acid group (-COOH). The a-carbon contains a hydrogen atom and an R
group, known as the side chain. The basic structure of all amino acids is shown in Figure
l - l . The side chain determines most of the chemical features of the amino acids, and
thus is used as the basis for categorizing them. They are divided into four groups, based
on the sidechain, 1) non-polar, neutral amino acids, 2) polar, neutral amino acids, 3)
negatively-charged amino acids, and 4) positively-charged amino acids. The non-polar
amino acids are glycine, valine, alanine, leucine, isoleucine, methionine, phenylalanine,
tryptophan, and proline. The polar amino acids are serine, threonine, cysteine, tyrosine,
asparagine, and glutamine. The negatively-charged amino acids are aspartic acid and
glutamic acid. The positively-charged amino acids are lysine, arginine, and histidine.

HO

NH
Figure 1-1: The typical structure of an amino acid. The figure above shows alanine.
The circled group is the sidechain, commonly referred to as an R group
To form a peptide, amino acids are linked together through a peptide bond. A
peptide bond occurs at the C-terminus of one amino acid and the N-terminus of the next
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amino acid. The reaction results in the release of a water molecule. An example of a
peptide bond is shown in Figure 1-2. Multiple amino acids can be joined together
through peptide bonds to form peptides and proteins. The structure, abbreviations, and
chemical properties of amino acids are included in Appendix A.

OH

NH

OH

NH.
Figure 1-2: The fonnation of a peptide between two lysines
1.1.2

Transcription and Translation
Protein synthesis is regulated through gene expression by both deoxyribonucleic

acid (DNA) and ribonucleic acid (RNA) in processes called transcription and translation,
respectively (Vogel, 2011). Transcription is the process by which a complementary
strand of RNA is created from DNA. This process takes place within the nucleus of the
cell. RNA polymerase reads the base pairing of the DNA gene, and places the
complementary base pair on the RNA molecule. The nucleotides in DNA are adenosine
(A), guanosine (G), thymine (T), and cytosine (C). Adenosine and thymine are
complementary bases (A-T), and guanosine and cytosine are complementary bases (C-G).
RNA uses the same base pairing, except that the nucleotide thymine is replaced with
uracil (U), which is the RNA complementary base pair for adenosine. Transcription is

the first step in gene expression. It is a multi-step process, resulting in the formation o f
RNA genes.
Most of these RNA are non-coding and serve other purposes inside the cell, but
one type of RNA, messenger RNA (mRNA), is used for the coding o f proteins. After
mRNA is transcribed, it is transported out of the nucleus and into the cytosol. There, the
mRNA goes to a ribosome, where the process of translation begins. During the process
of translation, the sequence o f the mRNA gene is read and the corresponding encoded
peptide is synthesized.
The nucleic acid, mRNA codes for amino acids through a sequence o f nucleotide
triplets, or codons (Frederick and Ibba, 2010). There are 61 codons that specify the 20
amino acids for protein synthesis. With few exceptions, this mechanism for protein
coding is universal through all species. The coding always begins at a START codon
(AUG), which codes for methionine. The coding continues in sequences of three
nucleotide base pairs until a STOP codon is encountered (UAA, UAG, or UGA). For
example, the mRNA sequence AAGCCACGC would encode for the three amino acids
lysine, proline, and arginine (Lys-Pro-Arg), all connected with peptide bonds. Figure 1-3
shows the three base sequences required for coding the amino acids.
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Second Position
code

Amino add

Amino acid

code

Amino acid

code

Amino

uuu
STOP

STOP

i

Figure 1-3: mRNA codons for transcribing proteins
1.1.3

Post-translational Modifications
Following translation, proteins are moved from the ribosomes to the endoplasmic

reticulum, where further modification through post-translational modifications occurs.
These modifications serve various functions. Some o f these functions include identifying
proteins for proteolysis (Shigi, 2012), regulating transcriptional activity (Duquet et al.,
2006), and regulating gene expression (Yang et al., 2010). These examples demonstrate
the biological relevance o f protein post-translational modifications. Figure 1-4 shows an
image o f a cell, with the key areas o f protein processing highlighted. These areas include
the nucleus (transcription), the ribosome (translation), and the endoplasmic reticulum
(post-translational modifications).
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Ribosomes

Nucleus

Mitochondrion
Cytoskeleton

Golgi
apparatus
Rough
endoplasmi
reticulum
Smooth
endoplasmic
reticulum

Centrioles
Peroxisome

Plasma membrane

Figure 1-4: The image of a cell, with the key locations for protein processing
highlighted
Other forms of post-translational modifications are induced with a cell is exposed
to external stresses. Two sources of stressors are reactive oxygen species (ROS) and
reactive nitrogen species (RNS). Some examples o f ROS include singlet oxygen,
hydrogen peroxide, and hydroxyl ions. A major source of RNS is NO. These species
both play critical roles in cell signaling (Klatt and Lamas, 2000), but when unregulated,
result in oxidative and nitrosative stress, respectively. These stresses can cause extensive
damage to biologically relevant macromolecules, including membrane lipids, proteins,
DNA, and lipoproteins.

1.2

Central Hypothesis

One o f the key markers of oxidative stress within a cellular system is the
production of carbonylated proteins. Carbonylation levels are generally associated with
in vivo oxidative stress conditions (Madian et al., 2011). Carbonylated proteins are
involved in a large number of human pathologies (Dalle-Donne et al., 2003); therefore,

7

these proteins could serve as biomarkers for these diseases. They also have the potential
to become novel therapeutic targets for the treatment of these conditions. However, we
do not have enough knowledge to determine the therapeutic or diagnostic capabilities of
these proteins. One o f the factors contributing to our limited understanding of these
proteins is their low abundance in samples. In order for research to be conducted on this
sub-proteome, the carbonylated proteins in the sample must be enriched.
Currently, the preferred methodology for carbonylated protein enrichment is
affinity chromatography, specifically avidin affinity chromatography. Carbonylated
proteins are derivatized with biotin hydrazide, which has an affinity for carbonylated
proteins. Avidin affinity chromatography takes advantage o f the strong affinity between
avidin and biotin for positive enrichment of a target. However, this technique has
significant drawbacks, including a large sample requirement, excessive sample waste,
and the need for a derivatization step. The process of affinity chromatography is also
time-intensive. Therefore, the work in this dissertation was organized to develop a more
efficient way to enrich carbonylated proteins so that their potential as disease biomarkers
could be assessed. The central hypothesis is that a microfluidic enrichment technique for
carbonylated proteins, utilizing oxalyldihydrazide as a novel crosslinker, will require less
sample, produce a smaller elution volume, and be less time-intensive than the current
enrichment technique o f avidin column chromatography.
The technique developed in this dissertation is microfluidic-based. Microfluidic
techniques require smaller volumes than conventional analytical techniques. The reduced
sample requirement would allow for easier translation into clinical settings. In addition,
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clinical samples, such as serum and biopsies, are considered very precious, and as such, it
is critical that these samples are not squandered using high-waste analytical methods.

1.3

Dissertation Aims

The three specific aims for this dissertation were as follows:
(i)

Develop and test a microfluidic enrichment technique for the selective and
specific capture o f carbonylated proteins. A novel surface modification
technique, utilizing oxalyldihydrazide, was created for the selective capture of
carbonylated proteins. Selective protein capture was tested using a model protein,
cytochrome c, oxidized in vitro. The specificity of the capture mechanism was
tested using a mixture o f our oxidized protein and a native form (unoxidized)
protein, bovine serum albumin (BSA).

(ii)

Optimize the microfluidic enrichment technique with respect to four variables to
reduce sample, waste, and time requirements. The four variables were the interior
post density of the microchip, the concentration of the crosslinker,
oxalyldihydrazide, the flow rate at which proteins were injected, and the amount
o f time that oxalyldihydrazide was allowed to incubate inside the microchannel
prior to being washed out of the channel.

(iii)

Determine the conditions at which the microfluidic enrichment technique would
fail. Because o f the novelty of the surface modification technique, the binding
energies of oxalyldihydrazide with poly (methyl methacrylate) (PMMA) and
amino acid residues were calculated. The results were compared with fluid
dynamics calculations for determining the conditions in which the microfluidic
enrichment technique would fail.
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1.4

Dissertation Outline

This dissertation consists of six chapters. Chapter 2 provides background
information about the established knowledge in the field. Topics covered include
oxidation and oxidative stress, protein oxidation, disease states where protein oxidation
has been implicated, a more detailed look at carbonylated proteins, history and
applications o f microfluidics and MEMS technology, a discussion about the historic uses
of oxalyldihydrazide, and some basics about the theoretical techniques used for model.
The chapter closes with a conceptual example of oxidative stress. Chapter 3 presents the
development o f the microfluidic carbonylated protein enrichment technique that stands at
the heart o f this dissertation. The optimization of the technique is discussed in Chapter 4.
Chapter 5 focuses on the theoretical determination of the conditions that would cause the
enrichment technique to fail. In Chapter 6, general conclusions are presented, including
future directions for the research and suggestions for improving the method.

CHAPTER 2

LITERATURE REVIEW

2.1

Oxidation and Oxidative Stress

Oxidation is a naturally occurring process in cell development that is used in
many cellular processes (Zhao and Jensen, 2009). The major source o f free radicals in an
organism is the mitochondria (Zhou et al., 2010; Finkel and Holbrook, 2000; and Balahan
et al., 2005), although other organelles within the cell, such as peroxisomes, also contain
oxidizing agents. Figure 2-1 shows the location of free radical stores and sources inside a
cell. During inflammation, these free radicals are released to oxidize foreign
macromolecules. Oxidation marks these foreign molecules for degradation by the
immune system. After these free radicals have completed their jobs, they are inactivated
by the anti-oxidant system, composed primarily of enzymes (Reed et al., 2008).
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Figure 2-1: Location o f the primary free radical stores and sources (peroxisome and
mitochrondrion) within the cell
If free radicals are not quickly neutralized by anti-oxidants, they begin to oxidize
macromolecules (lipids, DNA, and proteins) that are neither damaged nor foreign. This
damage to native tissue is called oxidative damage, with the cumulative effect labeled as
oxidative stress. Oxidative stress occurs over time (Chang et al., 2000), as an organism is
exposed to its internal stores o f oxidizing agents and those in its external environment.
Some physiological effects of oxidation include molecular switch action, enzyme
inactivation, and triggering of the apoptotic cascade (Alberghina and Colangelo, 2006;
Krause and Muller, 2010). These consequences become more pronounced as the
organism ages, as anti-oxidant efficiency decreases (Apelt et al., 2004). To further
diminish the anti-oxidant system’s efficiency, certain anti-oxidant enzymes become
oxidized and lose their function. An example such enzyme is superoxide dismutase
(SOD), whose function is to convert superoxide (O 2 ’) to hydrogen peroxide (H 2 O2 )
(Czapski et al., 2002). Hydrogen peroxide is broken down by catalase into water (H 2 O)
and oxygen (O 2 ) (Maehly and Chance, 1954). Oxidative stress has been implicated in

12

age-related processes and neurodegenerative diseases, such as Alzheimer’s Disease
(Nunomura et al., 2006).

2.2

Protein Oxidation

Oxidation is used by the immune system to fight foreign agents, such as in the
case of bacterial infection. However, when native tissues begin to be oxidized, the results
are detrimental to the cell. Some consequences of protein oxidation include protein
misfolding, loss o f function, loss o f solubility, and protein aggregation (Sultana et al.,
2010). There are 35 different ways that a protein can be oxidized, with many residues
having multiple oxidation products possible (Madian and Regnier, 2010). For a detailed
look at possible oxidation products, see Appendix.

2.3
2.3.1

Disease States Where Protein Oxidation has been Implicated
Alzheimer’s Disease

Hallmarks of Alzheimer’s Disease (AD) include cognitive impairment and
dementia. An official diagnosis of AD is not possible prior to autopsy, where
neurofibrillary tangles (NFTs) are observed. Increased levels of protein dysfunction and
de-regulation have been seen in cases of AD (Alberghina and Colangelo, 2006; Eckert et
al., 2010). Oxidative stress is hypothesized to be a contributing factor to the protein
dysregulation seen in AD. High levels of protein carbonylation, a key marker of
oxidative stress, have been observed in AD (Dalle-Donne, Rossi, et al., 2003). Recent
findings suggest a deterioration of the antioxidant system within the brain as a driving
factor toward the increased oxidative stress levels seen in the temporal cortex of aged
mice rats (Wang et al., 2010). It is believed that the neuropathology develops many years

before any clinical symptoms manifest (Sultana et al., 2010). However, the link between
protein oxidation and the physiological manifestations of AD still remains unclear.
2.3.2

Amyotrophic Lateral Sclerosis
A link has been suggested between oxidative stress and other neurodegenerative

diseases, such as amyotrophic lateral sclerosis (ALS) (Dalle-Donne et al., 2003). ALS is
a neurodegenerative disease that results in muscle wasting, paralysis, and death, often
within a two to three year period post-diagnosis. It has been suggested oxidative stress
plays a key role ALS, and as such, should be treated as a potential therapeutic target
(Barber and Shaw, 2010). Another study suggests the dysregulation of two key
antioxidants, glutathione and the enzyme superoxide dismutase-1 (SOD1), results in the
increased levels o f oxidative stress seen in this condition (Schulz et al., 2000; Fischer et
al., 2012; and Robberecht, 2000). However, the exact pathogenesis o f ALS is poorly
understood (Robberecht, 2000), requiring much more work prior to actively pursuing
oxidative mechanisms as a therapeutic target in ALS.
2.3.3

Inflammation
As stated earlier, one o f the effects of inflammation is the release o f oxidizing free

radicals. Organisms use this mechanism as a defense against foreign macromolecules.
However, inflammation plays a key role in several human diseases (Dalle-Donne et al.,
2003). Some o f these conditions include atherosclerosis and autoimmune diseases. A
study observed that the impairment of vascular reactivity in atherosclerosis was a direct
result of the reaction between NO and superoxide (O 2 ) to form the powerful oxidant
peroxynitrite (ONOO) (White et al., 1994). Peroxynitrite served as a potent mediator for
oxidation o f lipoproteins, as well as a substrate for (NO), which reduced the capability of
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the smooth muscle to respond to changes in blood flow. The production of ROS in the
skin causes protein damage in allergic and inflammatory skin diseases (Okayama, 2005).
A free radical pathway has also been suggested in systemic lupus erythematosus, and
further studies have implied a unifying theme of oxidative stress, including protein
oxidation, in the pathogenesis of these inflammatory autoimmune diseases (Kovacic and
Jacintho, 2003).
2.3.4

Aging
Denham Harman proposed the free radical theory of aging in 1954 (Harman,

1956). He proposed that irradiation induces cancer, mutations, and aging. One o f the
mechanisms o f this irradiation effect was the liberation of free radicals, including OH'.
The theory was later extended in 1972, adding the suggestion that superoxide was the
primary free radical from which most others stemmed (Harman, 2006). Mitochondria
aging effects were added to the theory in 1983. The effects o f tissue exposure to air were
examined in 1993. Through extensive work over the past 50 years, the free radical theory
of aging has been established as a valid and useful theory for explaining the aging
process in organisms (Harman, 2009).

2.4

Carbonylated Proteins

Carbonylation, the most widely accepted form of protein oxidation, has been used
as a marker for oxidative damage to proteins in vivo (Colak, 2008). Carbonylation is an
irreversible post-translational modification (PTM) that attaches an aldehyde functional
group to an amino acid residue (Madian and Regnier, 2010; Suzuki et al., 2010). The
most common residue targets for carbonylation are lysine, proline, threonine, and
arginine (Suzuki et al., 2010). While other forms of protein oxidation exist,

carbonylation is the most common, and thus best characterized. Carbonylated proteins
are often formed in vivo through metal-catalyzed oxidation reactions, one of the primary
means of enzymatic deactivation within the body (Amici et al., 1989). Typically, when
proteins are carbonylated, the proteins become more susceptible to proteolytic destruction
(Davis et al., 1987). Therefore, protein carbonylation can serve as a powerful tool in
cellular signaling (Wong et al., 2010), but the relationship between carbonylated protein
marking and destruction are poorly understood.
2.4.1

Detection o f Carbonylated Proteins in a Sample

There are techniques for detecting the existence o f carbonyls in a protein sample.
The first technique was proposed by Levine et al. (1990) and uses a spectrophotometric
assay called the DNPH assay. This assay derivatizes carbonyls with 2,4dinitrophenylhydrazine (DNPH) to form a hydrazone bond. Another technique for
detecting carbonyls is immunochemistry-based (Barreiro et al., 2005). Carbonyls are
derivatized with dinitrophenyl (DNP), and run through a gel. The gel is transferred to a
membrane, and the membrane is probed using the anti-DNP antibody. This method can
be used to visualize the presence of carbonylated proteins within a sample. Total
carbonyls can also be measured by enzyme-linked immunosorbent assay (ELISA) (Buss
et al., 1997), slot blotting (Robinson et al., 1999), or immunohistochemistry (Smith et al.,
1998). While DNPH methods of detecting carbonyls are the most prominent, other
techniques exist. One of these techniques uses sodium borotritide. This technique can be
used either in solution (Lenz et al., 1989) or as a reaction step prior to gel electrophoresis
(Yan and Sohal, 1998).
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2.4.2

Identification of Carbonylated Proteins

Proteomics is the study o f protein expression in an organism. Proteomics is closely
related to genomics. Because protein expression is tightly regulated by DNA and RNA
processes, a change in the genome could result in a change in protein expression. The
total collection of all proteins within the cell is called the proteome. Each cell, while
possessing the complete proteome, uses different factors and environment cues for
determining protein expression (Schulenborg et al., 2006). Therefore, the identification
o f proteins, specifically carbonylated proteins, is important. The field has been greatly
aided by the cooperation o f the scientific community in the creation o f online theoretical
databases, such as SwissPROT and MASCOT. Using mass spectroscopy, structural and
sequential information can be gathered. This information can even determine small mass
shifts (on the order o f Daltons) o f individual amino acid residues. This sensitivity allows
for in-depth analysis o f site-specific post-translation modifications. Through the use of
proteomics, a lot has been learned about protein expression in disease states (Schulenborg
et al., 2006; Marcus et al., 2004).
2.4.3

Measurements o f Carbonylated Proteins

When using the DNPH method for the determination o f carbonyls in a sample, a
hydrazone bond is formed between the carbonylated proteins and the hydrazine. The
bond formation is advantageous for measurements because it has a distinctive peak at
370 nm when analyzed using a spectrophotometer. Beer’s Law, given in Eq. 2-1 below,
is used for determining the carbonyl relative concentration:
A = ebc.

Eq. 2-1

In Eq. 2-1, A is the absorbance, e is the molar extinction coefficient, b is the
pathlength, and c is the concentration. Typically, the pathlength and the molar extinction
coefficient are known. The absorbance is found experimentally, using
spectrophotometry. Using the known terms, concentration o f the carbonyl content can be
found. The concentration is expressed in the units (nmol carbonyl)/ (mg protein).
Carbonyl content for individual proteins can be determined using a conventional one
dimensional (Keller et al., 1993; Yan et al., 1998) or two-dimensional (Nakamura and
Goto, 1996) sodium dodecyl sulfate (SDS) gel electrophoresis. This step would be
followed by a Western blot analysis. While this approach is more robust in terms of
selectivity and specificity than other carbonyl assays, it produces only semi-quantitative
results (Shacter, 2000).
2.4.4

Metal-catalyzed Oxidation
One o f the primary theories for protein oxidation in vivo is metal-catalyzed

oxidation (MCO). MCO is a site-specific reaction that results in the reduction of Fe (III)
to Fe (II), producing hydrogen peroxide (H 2 O2 ) in the process (Amici et al., 1989). The
residues most susceptible to MCO reactions are lysine, arginine, threonine, and proline.
Stadtman and Oliver (1991) suggested that MCO reactions are the primary mechanism of
increased protein carbonylation in numerous disease states.
2.4.5

Enrichment Requirements and Technology Gap
A limitation on carbonylation studies and a restriction on its use clinically is the

low abundance o f these proteins in a sample. In order to extract useful data, these
proteins must be enriched and purified. None of the three enrichment methods
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commonly used, affinity chromatography, strong cation exchange (SCX), and 2Dpolyacrimide gel electrophoresis (2D-PAGE), are ideal.
In affinity chromatography, most commonly, avidin column chromatography
(Mirzaei and Regnier, 2005; Yoo and Regnier, 2004), carbonyls are derivatized with
biotin hydrazide and flushed through the column. The high affinity between biotin and
avidin allow for the labeled proteins to be captured. Elution occurs by rinsing the column
with excess biotin. Disadvantages of traditional affinity column chromatography include
the amount of sample needed for the protocol, the amount of reagents needed, and the
time requirements, the high dilution of the eluted targets, and the need for a derivatization
step. Recent work has been done to miniaturize the avidin column onto a disposable
PMMA microfluidic chip (Xia et al., 2012). The study demonstrated a 106-fold reduction
in the amount of sample needed from the commercially available technology. The use of
a microfluidic platform also reduced the time needed for the sample analysis. However, a
derivatization step with biotin hydrazide, a time intensive step, is still required.
Strong cation exchange (SCX) takes advantage of Girard’s P Reagent (GPR).
GPR contains a hydrazide group for derivatization with carbonyls, as well as a quaternary
amine that can be selected using SCX at pH 6.0. This approach is often used in
combination with reverse-phase chromatography coupled with tandem mass spectroscopy
(RPC-MS/MS). While an advantage of this technique is that excess reagent does not
have to be removed after derivatization, the approach requires a trypsin digestion of the
GPR-derivatized proteins, adding overall analysis time to the technique (Madian and
Regnier, 2010).
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In 2D-PAGE, proteins are moved to their isoelectric point (pi) in a pH gradient
strip. Then, they migrate down the gel, separating by molecular weight (Schulenborg et
al., 2006). Once separation is completed, selected bands can be excised and analyzed
using MS. Limitations to this technique include the time needed for analysis and the
inability to determine if a band is composed o f more than one protein while on the gel.

2.5
2.5.1

Microfluidics and MEMS

History
Microfluidics refers to the use of fluidic devices on the spatial scale o f 1 —

100 pm (Ghosal, 2012). The field o f microfluidics is still considered immature. Most of
the progress in the field has occurred within the last decade. It is difficult to find
examples o f the first “microfluidic” device, but if the spatial definition is recognized, the
first ink-jet printers, patented in 1951, would qualify as microfluidic devices. The first
commercially available “lab on a chip” was sold by ALIGENT in 1999. Despite its brief
history, the field has rapidly emerged to the forefront of scientific exploration. This
emergence is seen through the number of patents issued related to microfluidics; in the
nineties, there were only a few. Today,the number o f patents exceeds 350 annually.
Microfluidics is promising for collaborative science because it incorporates principles
from physics, chemistry, engineering, and mathematics. For certain applications,
including a few discussed in this dissertation, biological considerations must be applied
as well (Grayson et al., 2004).
2.5.2

Manufacturing Techniques
The simplest microfluidic devices are manufactured relatively inexpensively and

require little expertise. A microfluidic device can be constructed using two glass

microscope slides, a drill press, double-sided tape, and a cutting device, such as a knife.
On one glass slide, place a strip o f double-sided tape. Using the knife, the design of the
channel can be cut into the tape. Two holes are drilled into the remaining microscope
slide for an entrance and exit reservoir. The microfluidic device is sealed by pressing the
two glass slides together. For smaller-scale features, a laser could be used to cut the
chip’s design.
For wet and dry etching of a pattern onto the surface of a microchip, a technique
called soft lithography, or photolithography, is first employed (Kim et al., 2008). The
process is shown schematically in Figure 2-2. Photolithography is the process by which
the mold master is formed, which is then used for the formation of the stamp for creating
microfluidic channels. This contrasts with the way in which the mold master is created
for hot embossing. For hot embossing, the mold master is formed through the process of
micromilling. Typically, the starting substrate is silicon, with a thin layer o f silicon
dioxide on top. A photoresist can be applied to the substrate. There are two types of
photoresists, negative and positive. The classification is dependent upon how the
substance reacts to UV radiation. Following the application o f the photoresist, the
substrate is exposed to UV irradiation. Post UV-exposure, the photoresist is developed.
It is during development that the type of photoresist chosen becomes important. When a
positive photoresist is exposed to UV radiation, its crosslinks are weakened. UV-exposed
photoresist is removed during development. Negative crosslinkers, on the other hand, are
strengthened by exposure to UV radiation. Therefore, the areas not exposed are removed
during development. The substrate is then etched using wet or dry etching techniques.
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Lastly, the photoresist is stripped from the substrate, and the master can be used for the
construction of microfluidic devices.

Starting substrate (Si)
NEGATIVE PHOTORESIST

1. Apply photoresist

m■ a
Photoresist

S

n ^ n
3. Develop photoresist
2. Expose photoresist

4. Etch substrate

5. Strip photoresist

POSITIVE PHOTORESIST

Figure 2-2: Flowchart for the use of photolithography to create a microfluidic device
Silicon is one o f the most popular base substrates used in microfluidic devices.
Silicon is suitable for a variety of applications, due to desirable mechanical properties,
including high melting temperature and a high strength-to-weight ratio (Ayon et al.,
2001). However, the substrate requires etching prior to being used as a microfluidic
device. There are three methods for achieving this, mechanical etching, dry etching, and
wet etching. Mechanical etching is easier, but cannot generate smooth surfaces. Dry
etching is effective, but has a low etch rate. Wet etching is the most common form of
etching for silica-based microfluidic devices (Iliescu et al., 2007). Solutions based upon
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hydrogen fluoride (HF) are used for wet etching. Even though wet etching has a high
etch rate, one of the trade-offs is less control over the profile due to an isotropic etching.
Because the substrate is immersed in solution, the etching occurs equally in all directions.
Whereas wet etching involves the immersion o f a substrate, such as silicon, to
etch the desired pattern, dry etching involves the bombardment of the substrate surface
with high energy molecules (Kameoka et al., 2001; Chun et al., 2006). The high energy
molecules etch the substrate pattern by colliding with the surface of the substrate.
Another term for dry etching is reactive ion etching (RIE). Dry etching can give higher
profile control than wet etching, due to anisotropic etching. In this case, the photoresist
provides additional protection, as the high-energy molecules can only contact the
substrate where there is no photoresist. The difference results in smoother surfaces for
dry etching vs. more rounded features in wet etching. However, the tradeoff for
additional control over the microfluidic profile is the lower etching rate.
Hot embossing is seen as an alternative to the fabrication techniques primarily
used for silicon or glass-based MEMS (wet and dry etching, discussed above) (Becker
and Heim, 2000). This technique is a low cost microfabrication technique applied to
polymer substrates, typically PMMA or polycarbonate (PC). Figure 2-3 shows how hot
embossing is used for the construction of a microfluidic device. Figure 2-4 shows a
schematic of a typical hot-embossing system. The two platens in the system (upper and
lower) are attached to thermocouples, allowing for their temperatures to be controlled
independently. The metal mold master is placed in contact with the polymer substrate
and held there to emboss the negative o f the master onto the substrate. The process is
completed within a vacuum chamber. The high temperatures and contact force used in
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hot embossing make the technique undesirable for use with other microfluidic substrates
based on silica.

Starting metal mold

1. Mill metal mold to create a master

2. Emboss structure onto polymer surface

Heat and contact force

3. Remove polymer substrate and allow to cool

Figure 2-3: Process for the use o f hot embossing for the creation o f a microfluidic
device
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Figure 2-4: Schematic of a typical hot embossing system
Polymer-based microchannels are advantageous to life sciences applications.
Some of the advantages polymers have over glass-based substrates include having a wide
range o f material properties, allowing for the substrate to be optimized to the application.
In addition, polymers have a high volume fabrication for low material costs (a necessity
for disposability) and the microfabrication is simplified because of the replication
methods. In some o f the earlier descriptions o f work using hot-embossing, polymer
based microfluidics were used for chromatographic columns (Arnold et al., 1998), DNA
concentrators (Christel et al., 1998), DNA separations (Simpson et al., 1998), and
capillary electrophoresis (Llopis et al., 2007). PMMA and PC are the main two polymers
used for hot embossing. Tabie 2-1 shows the conditions for using hot embossing on these
two substrates. PMMA has some advantages over PC, in particular, its lower glass
transition temperature (Tg) and the lack of toxic chemicals leeching off the substrate.
Therefore, PMMA is the substrate used for the experiments described within this
dissertation. Due to the limitations o f micromilling being a mechanical etching
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technique, all microfluidic devices formed by this method will have an inherent
roughness to them. Table 2-2 shows a side-by-side comparison of the etching techniques
used in microfluidic device construction.

Table 2-1: Hot embossing conditions for PMMA and PC.

Material

Tg (°C)

Embossing
Temperature
(°C)

PMMA

106

120-130

20-30

30-60

PC

150

160-175

20-30

30-60

Embossing
Force (kN)

Hold Time (s)

Table 2-2: Comparison o f different techniques for the manufacture of microfluidic
devices.
Etching
Technique

Control

Etching
Speed

Feature
details

Photolithography
required

Substrate

Wet
etching

Low

Medium

Less
detail

Yes

Silica

Dry
etching

Medium

Slow

More
detail

Yes

Silica

Hot
embossing

High

Fast

Most
detail

No

Polymer

2.5.3

Applications
Miniaturization and automation are gaining popularity in biomedical research

labs, primarily because of the reduced analysis times and reduced human participation
(and consequently, error). An example o f an analytical technique that has undergone
miniaturization is electrophoresis. Originally, this technique was completed in a gel on a
benchtop. An advance to this approach was the introduction o f capillary electrophoresis

(CE), which can be coupled to a laser light source for laser-induced fluorescence studies
(CE-LIF) (Feng and Arriaga, 2008; Feng et al., 2008). This technique combines the
resolving power of gel electrophoresis with the sensitivity of fluorescence. When
combined with the automated control of the experiment, this technique has advantages
over traditional gel electrophoresis (Osiri et al., 2008; Shadpour et al., 2007). Now, 2Dmicro-CE-LIF (2D-pCE-LIF) is possible and has been reported in the literature (Osiri et
al., 2008; Shadpour and Soper, 2006; Wang et al., 2012). This technique offers a few
advantages over CE-LIF. Some of these advantages include smaller size, faster migration
times, smaller samples, and higher resolving power (Osiri et al., 2008; Shadpour and
Soper, 2006; Wang et al., 2012). The technique can also be coupled directly to mass
spectroscopy.
Because o f their small volume, reagent requirements, and high-throughput
capacity, microfluidic devices are excellent for drug screening. Numerous studies have
been conducted on drug effectiveness inside the chamber of a microfluidic device. One
study used a microfluidic device to detect bacteria within a sample (Boedicker et al.,
2008). The researchers also analyzed the bacteria’s susceptibility to different antibiotics
inside the microchannel. Using this methodology, the authors were able to identify the
antibody sensitivity o f methicillin-resistant Staphylococcus aureus (MRSA) using
multiple antibiotics in a single experiment. Another study created a high throughput
method to quantify the motility of a parasite (Smout et al., 2010). This study is
concerned with the pre-emptive detection of livestock parasites prior to human infection.
The importance of this technique was that it conducted real-time drug screening. This
screening allowed for the quick identification o f drug resistance development in the
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parasite. Microfluidics provides a great platform for pharmaceutical research and drug
development, including the simple coupling with micro-titre technology for more
efficient drug discovery techniques (Tolan et al., 2008; Kang et al., 2008).
2.5.4

Microfluidic Cell Capture and Enrichment
In the past decade, microfluidic devices have been used to reduce the reagent

requirements in cell culture. In one o f the studies, a technique was developed to control
the microenvironment in cell culture (Young and Beebe, 2010). This study was one of
the first to look at cell biology principles within a microfluidic device. The technique has
the promise to revolutionize the way cell biology is conducted in the future.
However, at the intersection of cell research and microfluidic technology, most
attention is paid to the capability of microfluidics to provide a great platform for cell
capture. In particular, positive enrichment o f cancer cells has been one o f the primary
goals o f using microfluidics in cell biology. This enrichment has been accomplished
using different techniques. One o f the techniques was the use of aptamers for selective
capture o f prostate-specific membrane antigens (PSMA) (Dharmasiri et al., 2009). AntiPSMA aptamers were immobilized onto the surface of a PMMA microchip, and sample
was loaded into the chip. The analysis was completed in a high-throughput manner, with
1 mL of solution being analyzed in less than 30 minutes. The PSMA could be released
from the channel completely intact, allowing for easier analysis post-chip.
Another technique for capturing cells inside a microchip involved the
immobilization of antibodies onto the surface of a microfluidic chip (Nagrath et al., 2007;
Adams et al., 2008). These studies analyzed the capture of rare circulating tumor cells
(CTCs) from a sample. The authors used anti-EpCAM antibodies for the detection o f
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CTCs associated with prostate and breast cancer, respectively (Nagrath et al., 2007,
Adams et al., 2008).
Another technique used electromagnetism as the mechanism for cell enrichment
on a microchip. One research group used self-assembled magnetic beads for the selective
capture o f cancer cells (Saliba et al., 2010). The researchers were able to type the cancer
cells on-chip as well using the technique. All o f these examples demonstrate notable
advances to cancer biology studies, as well as the high adaptability of microfluidics and
microelectromechanical systems (MEMS) towards almost any application.
2.5.5

Promise for Novel Diagnostic Tools
Biomedical applications of MEMS (BioMEMS) typically address diagnostic or

therapeutic goals. Advances in lab-on-chip diagnostic systems and implantable
therapeutic biomedical microdevices, such as implantable electrodes, have paved the way
for novel treatments to improve quality o f life (Cheung and Renaud, 2006). In the future,
these devices will continue to make contributions to the advancement o f health science.
Even now, the technology exists for the development of “smart” lab on chip technology
for point-of-care clinical diagnosis (Ahn et al., 2004). These devices are small, portable,
and have a self-contained power source. This combination makes for simple use in the
field when access to standard medical equipment is difficult or unrealistic to obtain. The
addition o f renewable power supplies to this technology is being pursued to make it
available in places like home health and developing countries (Weigl et al., 2008). These
adjustments would lead to devices that are both minimally-invasive and minimallyinstrumented. A simplified diagnostic tool reduces both the need for specialized

29

equipment for diagnosis and extensive training for analyzing the results. Microfluidics is
also being applied provide additional novel diagnostic functionality.
The use of MEMS provides a promising platform for protein analysis, especially
low abundant proteins, where samples may be limited or difficult to obtain (Diercks et
al., 2009). Microfluidic chips, composed of materials such as glass or silicon, are usually
simple to construct using basic photolithography techniques. In the last decade,
polymeric chips have become increasingly popular, due to their versatility and lower cost
(Becker and Lacascio, 2002; Stachowiak et al., 2003). Particularly, high precision
micromilling for metal mold master fabrication is desirable for researchers who do not
have access to extensive lithography based equipment. The combination low cost and
mass production allows these chips to be disposable, reducing the likelihood of cross
contamination between samples on a reused chip. Fast analysis, high throughput, and
low reagent consumption are advantages of BioMEMS over conventional techniques for
low-abundance samples.

2.6
2.6.1

Oxalyldihydrazide

Historic Uses
Oxalyldihydrazide is a small molecule (MW = 119.6) that has a two carbon

backbone. Each carbon is double-bonded to an oxygen atom (C=0), and single bonded
to a hydrazide functional group (-NHNH 2 ). Figure 2-5 shows the chemical structure of
an oxalyldihydrazide molecule. More recently, it has been used in the synthesis of
biologically active compounds derived from oxalyldihydrazide and complexes it forms
with different metals (Singh et al., 2009; Aruna and Patil, 1998; Aggarwal and Singh,
2004). It was originally applied in a method for determining copper content within a
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sample, particularly blood (Stark and Dawson, 1958; Beale and Croft, 1960; Kekki and
Siltanen, 1960). It has also been used in a colorimetric assay to determine phosphate
levels in drinking waters and soil for environmental monitoring (Salem, 1991).

o

NH— NH2

Figure 2-5: Chemical structure of an oxalyldihydrazide molecule
2.6.2

Reasons for Choosing Oxalyldihydrazide as the Enrichment Crosslinker
Even though the molecule had never been used before for microfluidic

enrichment, there are reasons to believe the molecule would work as an effective
crosslinker for this project. As demonstrated through the continued use of the DNPH
assay, carbonyl groups have a strong affinity for hydrazide. Therefore, it was necessary
to have a hydrazide functional group available for reacting with the carbonyl group o f the
carbonylated proteins. Microfluidic devices, especially polymer-based chips, lend
themselves well to surface modification (Dharmasiri et al., 2010; Bai et al., 2006; Lee et
al., 2005). Therefore, proper surface modification would allow the successful
immobilization of oxalyldihydrazide onto the channel surface. Chapter 3 provides
experimental support for the process. The crosslinking is verified further in theoretical
modeling presented in Chapter 5. Figure 2-6 shows a simplistic scheme for crosslinking
oxalyldihydrazide to the PMMA substrate.

31

UV exposure

SC

o
o
o
PMMA

X

o
o
o

DC

Crosslinking

o
o
u

Xcc

Xc3

X03

o

o

o

X

PMMA

X

X

PMMA

Figure 2-6: Scheme for immobilizing oxalyldihydrazide onto the surface of PMMA

2.7

Theoretical Modeling

Oxalyldihydrazide has not been used for microfluidic enrichment prior to the
work presented in this dissertation. It is important to examine the aspects that can lead to
failure of the enrichment technique. Failure will depend on the energy and critical
velocity required to break the bond formed between oxalyldihydrazide and PMMA and
oxalyldihydrazide and amino acid residues of carbonylated proteins. Therefore, density
functional theory was used to simulate these reactions and calculate the binding energies,
and Stokes’ law was used to determine the critical velocity is calculated.
2.7.1

Density Functional Theory
Density functional theory (DFT) is based on functions that describe the ground

state of a multi-electron system by using electron density (Li et al., 2012). DFT is more
efficient than other theories that involve electronic structures because it reduces the
number of variables required to complete the calculation. The process is not
computationally costly and the results are relatively accurate compared to other methods.
Therefore, DFT is seen as an acceptable method for calculating bonding strengths,
reactivities, molecular properties, and structural analysis (Bealing et al., 2012). For
additional details on density functional theory, refer to Kunjumon (2011).

2.7.2

Critical Velocity Calculation
If it is assumed that excessive shear stress will break the bonds between

oxalyldihydrazide and the protein, then the critical velocity that would cause such
breakage can be determined using Stokes’ Law. Assuming that the protein, of radius r is
immobilized and stationary and exposed to a fluid flow velocity, v, then Stokes Law
gives the total force on the protein as:
F = 6nr\rv,

Eq. 2-2

given by Bell (1978). In the equation, T] is the viscosity of the flowing fluid. A critical
force can be determined using the binding energy determined from the DFT calculations.
Because the critical force is directly proportional to the critical flow velocity, the critical
flow velocity can be calculated. For additional details on Stokes’ law and its application,
see Bell (1978).
2.7.3

Diffusion o f a Protein through a Channel
For a small molecule in a flowing field of velocity v inside a channel of length L,

the distance o f diffusion inside the channel can be calculated using Eq. 2-3:

Using the protein cytochrome c as the diffusing molecule, a diffusion distance
inside a microchannel o f length 1.5 cm in a flowing velocity o f 0.1666 cm/s can be
calculated as shown in Eq. 2-4. The diffusion coefficient was taken from experimental
data presented by Kontturi et al. (1992):
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d =

(1.65

x 10"6)(1.5)
0.1666

d — 0.0038 cm or 38 pm.

2.7.4

Eq.2-4

Eq. 2-5

Oxidative Stress Block Diagram
Figure 2-7 shows a flowchart of the oxidative stress process. When an organism

is exposed to a foreign entity or suffers an injury, an inflammatory response occurs. This
response triggers the release of ROS into the cytosol, which contributes to oxidative
stress. This event is transient as ROS activity activates the anti-oxidant system. Anti
oxidants inactivate the ROS, stopping further oxidative stress. Cumulative oxidative
events contribute to aging. Aging inhibits the activity of the anti-oxidant system, as the
enzymes break down over a lifetime. Some enzymes are even oxidized under oxidative
stress conditions, such as superoxide dismutase (SOD). So, as demonstrated in the block
diagram, oxidative stress is a cumulative process that expands, even under short, transient
conditions.

34

Inflam m atio n

R O S Activity

O x id ativ e S tress

A n ti-O x id a n t
System

Figure 2-7: Flowchart o f the oxidative stress process
2.7.5

One-compartment Model o f Oxidative Stress in the Cytosol
The effects of oxidative stress will be demonstrated further by analyzing a one-

compartment model o f anti-oxidant activity inside the cell cytosol. The model is shown
in Figure 2-8. The model is based on the activity o f catalase, an enzyme that degrades
hydrogen peroxide into water and oxygen. There are five assumptions for this model.
1. All catalase activity is included in the clearance
2. ROS introduction is treated like a bolus injection
3. No ROS is present in the cytosol prior to the introduction
4. Ke = Kcat o f catalase
5. All activity takes place in the cytosol, therefore organelles are not
considered in this model.
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ROS introduction
(bolus)

Clearance, ke

Figure 2-8: One-compartment model of the cell cytosol
There are three conditions investigated within the model.
1. Physiological conditions: 50 pM H 2 O 2 , 100 % catalase activity
2. Inflammation response: 100 pM H 2 O 2 , 100 % catalase activity
3. Aging condition: 50 pM H2 O2 , 20 % catalase activity

The governing equation is given as follows:
— = - k eC + C08 (t),

Eq. 2-6

where
D

Eq. 2-7

The boundary condition, C = 0 at t = 0, will be used because there is no ROS
present in the system prior to injection, as given by Assumption 3. Applying the
boundary condition to Eq. 2-6, the equation simplifies to Eq. 2-8:

Eq. 2-8
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With the initial condition C = C0 at t = 0, the solution to the differential
equation is:
C = C0e~ket,

Eq. 2-9

where, according to Assumption 4, k e = 4 x 107, and where C0 takes different values,
according to the three stated conditions. The solutions for the equations, with these
constant values are as follows:
Condition 1:
C = 50e~4xl°7t,

Eq. 2-10

C = 1 0 0 e"4xl°7t,

Eq. 2-11

C = 50e~8xl°6t.

Eq. 2-12

Condition 2:

Condition 3:

The half-life of the reactive oxygen species is important to consider when looking
at an oxidative stress situation. Half-life can be calculated from Eq. 2-13:
ty

=

ln(2)
ke

Eq. 2-13

From Eq. 2-13, the half-lives for the stated conditions are:
Condition 1: 17.32 ns
Condition 2: 17.32 ns
Condition 3: 86.62 ns
These results indicate that half-life depends on the enzymatic activity of the anti
oxidant system, and not the amount of oxidants present. If the activity o f the enzyme is
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maintained, the oxidants will be inactivated before they can do heavy oxidative damage
to native tissues.
The area under the curve (AUC) is the integral of the concentration, which is
directly related to oxidative stress. It is calculated from Eq. 2-14:
Eq. 2-14
The solution o f Eq. 2-14 is Eq. 2-15.
Eq. 2-15
The two solutions to AUC in Eq. 2-15 are the result o f a manipulation of Eq. 2-13
that relates ti^ to k e. Applying Eq. 2-15 to the conditions generates the following
results:
Condition 1: 1250 pJVTns,
Condition 2: 2500 pM ns,
Condition 3: 6250 pM ns.
The model gives valuable insight into the workings of oxidative stress, even
though it is simplistic in nature. The AUC results tell us that under transient
inflammation response and in aging conditions, oxidative stress increases at a greater
rate. These results imply that an organism suffers oxidative stress over the course of its
life through enzymatic inactivation and through immune responses.

CHAPTER 3

MICROFLUIDIC ENRICHMENT TECHNIQUE DEVELOPMENT

3.1

Introduction

In this chapter, the development o f a novel microfluidic enrichment technique for
carbonylated proteins will be discussed. In vitro oxidized cytochrome c is used as a
model protein. Capture is achieved through specific manipulation o f the PMMA polymer
to attach oxalyldihydrazide, a crosslinker specific to carbonyls, to the surface of the
microchip. In vitro oxidized BSA is used to verify the working of the surface
modification and in vitro oxidized cytochrome c is used as the target molecule to
demonstrate the selectivity o f the chip. Finally, the study is concluded with analysis o f
the technique’s ability to capture low abundance target proteins from a mixture
containing an excess of a large blocking protein. Surface modification o f PMMA is
verified through unique analytical techniques. Surface elemental analysis and roughness
were examined by X-ray Photoelectron Spectroscopy (XPS) and Atomic Force
Microscopy (AFM), respectively. Additionally, fluorescence microscopy was used for
chemical functional groups mapping to verify the presence of desired crosslinkers. This
work is the first to propose the use of oxalyldihydrazide as a method of carbonylated
protein enrichment. Use o f a crosslinker that is specific to carbonyls eliminates the need
for derivatization, extensive washing, and preconcentration steps afterwards. In addition,
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this is the first report of carbonylated protein enrichment through coupling the use of a
crosslinker to a microchip. Portions of this chapter are published in Hollins et al. (2012).

3.2
3.2.1

Materials and Methods

Materials
PMMA sheets were purchased from Goodfellow. 2,4-dinitrophenylhydrazine

(DNPH), EDTA, HEPES, potassium chloride, magnesium chloride, sodium ascorbate,
iron(III) chloride, hydrochloric acid, formic acid, N-(3-dimethylaminopropyl)-N’ethylcarbodiimide (EDC), albumin, tetramethylrhodamineisothiocyanate (TRITC-BSA)
and bovine serum albumin were purchased from Sigma Aldrich (St. Louis, MO).
Oxalyldihydrazide was purchased from Alfa Aesar (Ward Hill, MA). Nhydrosuccinimide (NHS) was purchased from Thermo Scientific (Rockford, IL).
Naphthalene-2,3-dicarboxaldehyde (NDA) was purchased from Invitrogen (Eugene, OR).
Cytochrome c was purchased from EMD Chemicals (Gibbstown, NJ).
3.2.2

Metal Catalyzed Oxidation
Bovine serum albumin (BSA) and cytochrome c were dissolved at 10 mg/mL and

5 mg/mL, respectively, in oxidation buffer (50 mM HEPES buffer, pH 7.4, containing
100 mM KC1 and 10 mM MgCE). The proteins were oxidized in vitro using metal
catalyzed oxidation (Amici et al., 1989). Briefly, 30 mL of oxidation buffer containing
proteins was supplemented with neutral ascorbic acid and FeCl3 , to final concentrations
of 25 mM and 100 pM, respectively. The mixture was incubated overnight at 37° C in a
shaking bath. Oxidation was terminated by adding EDTA to a final concentration of
1 mM. Proteins were aliquoted and frozen at -20° C until use. Proteins were diluted to
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required concentrations prior to experiments. Successful oxidation was confirmed using
the spectrophotometric DNPH assay.
3.2.3

DNPH Assay of Proteins
Protein oxidation was characterized using the well-established DNPH

spectrophotometric assay. A 500 pL solution o f 2 M HC1 containing 10 mM DNPH was
prepared. 100 pL o f oxidized BSA was added to the solution and allowed to sit at room
temperature for one hour. After incubation, TCA was added to a final concentration of
10 % (w/v) and the solution was incubated on ice for thirty minutes to precipitate the
proteins. The solution was centrifuged for 3 minutes at 11000 rpm and the supernatant
was discarded. The protein pellet was washed in a solution composed o f equal parts
ethanol and ethyl acetate. After each wash, the solution was centrifuged at 11000 rpm for
90 seconds and the supernatant was removed. After washing, the protein pellet was
redissolved in 6 M guanidine. Absorbance was read using a Nanodrop 2000 UV/Vis
spectrometer at 370 nm to determine the concentration of carbonyls in the oxidized BSA
model.
3.2.4

Off-chip Protein Loading
Prior to experiments inside the channel, oxidized cytochrome c was labelled with

naphthalene-2,3-dicarboxaldehyde (NDA), a fluorogenic probe (Pinto et al., 2003).
Briefly, NDA was dissolved in 100% methanol. 100 pL of 2 mg/mL oxidized
cytochrome c was placed in a tube. 400 pL of 10 mM borate buffer (pH 9.4) was added
to the tube, followed by 100 pL o f 10 mM KCN dissolved in water. Lastly, 400 pL of
5 mM NDA/methanol stock was added to the tube. The tube was allowed to incubate for
30 minutes at room temperature. Following incubation, the sample was rinsed in an
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Amicon Ultra-4 centrifugal filter unit (3,000 MW cutoff) to remove any unbound NDA.
The rinse was done in 10 mM borate buffer for 20 minutes. The solution was spun down
to about 200 pL, and the sample was supplemented with 800 pL of borate buffer to give a
total volume o f 1 mL.
3.2.5

Microchip Fabrication
The microchip used in these experiments is shown in Figure 3-1. The bed o f the

PMMA channel has microposts of 100 pm diameter. The depth of the channel is 50 pm,
and the length o f the channel is 12.5 mm. The capture bed is 1 mm wide, containing
150 microposts. The post-to-post spacing is 150 pm. The surface area available for
protein capture is 27.6 mm . Because the channel is relatively wide, the posts are
included to prevent the coverslip from collapsing into the channel during annealing. The
reservoirs are 1.6 mm in diameter. The chip fabrication process started with the
micromilling o f a mold master. Specifically, the above-mentioned microstructures were
milled on the surface o f a 6.3 mm thick brass plate (alloy 353 engravers brass, McMaster
Carr, Atlanta, GA) using a high-precision micromilling machine (Kern Mmp 2522, Kern
Micro-und Feinwerktechnik Gmbh & Co. KG; Germany). A typical milling cycle started
with a rough milling to prepare an approximate shape for subsequent finishing cut. The
feed rates were 20 mm/min for a 50 pm drill bit.

Figure 3-1: The microchip used in the studies discussed in this chapter
PMMA sheets (Plexiglas MC, GE Polymershapes, New Orleans, LA) were cut
into 65 mm diameter discs and cleaned by rinsing with 2-propanol and distilled water.
After removing residual moisture by placing them in an oven at 75 °C overnight, the
milled microstructures were pressed into the chips using a commercial hydraulic press
(PHI Precision Press model TS-21-H-C, City of Industry, CA). A home-built vacuum
chamber was installed into the hot embossing press to keep ultra-low air pressure
(< 10 kPa) for complete filling of the mold master. The embossing was performed at a
force o f 5 kN for 5 minutes at 155 °C. After embossing, injection and collection
reservoirs were created by using a drill press and a 1/16” black oxide drill bit. For the
final assembly, a thin PMMA cover plate of 250 pm thickness (Goodfellow, Oakdale,
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PA) was thermo-bonded to the face o f the micropost array chip. For this purpose, the
microfluidic chip and the cover plates were clamped between two 3” x 3” glass plates
(McMaster) and placed inside a convection oven at 97 °C for 30 minutes. PEEK tubing
(800 pm diameter) was attached to enclosed microchips using EPOXY. Chips were
stored until ready for use for experiments. Prior to experiments, the chips were
connected to a syringe pump using a LUER connector. The instrumental setup is shown
in Figure 3-2.

PEEK tubing

M icrochip

Syringe Pump

MicroChannel

Reservoirs

Figure 3-2: Instrumental setup used for loading the microfluidic device
3.2.6

PMMA Surface Modification
The PMMA surface was modified according to the first two steps shown in Figure

3-3 to produce a PMMA chip containing a crosslinker with hydrazide functions that
immobilize carbonylated proteins onto carbonyl and ketone moieties. Exposure to UV
radiation functionalized the PMMA chips with a carboxylic acid group, after which this
group was modified by the crosslinker oxalyldihydrazide to provide a hydrazine group.
These groups could then react with the carbonyl group of the proteins of interest to form
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hydrazone linkages. The proteins of interest (BSA and cytochrome c) could then be
removed from the modified PMMA with formic acid and heat.
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Figure 3-3: Chemical scheme employed for the enrichment of carbonylated proteins
within a microchip.
Prior to surface modification, the microchips were cleaned using Micro-90 in
water and rinsed with 10 % isopropanol and water. Excess fluid was removed under a
flowing stream o f nitrogen and dried in an oven at 70 °C to evaporate any water trapped
in the microstructures. 250 pm PMMA cover slips were cut to enclose the
microstructures. Both the microchips and cover slips were then exposed to ultraviolet
light (254 nm, 15 mW/cm2) for one hour. After UV exposure, the chips and cover slips
were pressed together for annealing. Afterwards, PEEK tubing was attached to the
injection reservoir o f the chips. A syringe pump was used to pump 100 pL o f MES

buffer containing 200 mM EDC and 50 mM NHS through the channel at a flow rate of
10 pL/min and the solution was allowed to incubate for 30 minutes. After the incubation,
100 pL o f 50 mM oxalyldihydrazide dissolved in MES buffer was flushed through the
channel at a flow rate o f 10 pL/min and allowed to incubate overnight. The channels
were loaded with proteins the following morning. Solutions of NHS, EDC, and
oxalyldihydrazide were prepared fresh daily. For experiments conducted on PMMA
sheets, the same procedure was used for surface modification. Figure 3-4 shows an
overall flow chart of the surface modification procedure.

Start with
micromilled PMMA
chip

Crosslink PMMA
with
oxalyldihydrazide

Clean PMMA and
dry overnight in oven

Attach PMMA to
PEEK tubing

Expose PMMA to UV
light

Thermal bond
PMMA

Verified using
analytical techniques
(AFM, XPS)

----- »

Block non-specific
binding sites with
BSA
Load proteins into
chip and incubate for
two hours

Verified using both
analytical/fluorescence
techniques

Figure 3-4: Flowchart for the enrichment procedure on a microfluidic device
3.2.7

Validation o f Surface Chemistry
Surface modification was validated at each step of the procedure using a PMMA

sheet. Successful UV exposure was demonstrated using water contact angle
measurements. All modification steps were analyzed using X-ray Photoelectron
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Spectroscopy (XPS) and Atomic Force Spectroscopy (AFM). For XPS and AFM studies,
PMMA sheets were treated with UV radiation, and then incubated in 1 mL of EDC/NHS,
oxalyldihydrazide, and proteins. After incubation, each sheet, it was rinsed in dFEO and
dried under a flowing stream o f nitrogen and stored until analysis.
For XPS analysis, all modified and pristine PMMA surfaces were measured by a
Karatos AXIS ultra-X-ray photoelectron spectrometer using a monochromatic Al Ka Xray source (240 W) and charge neutralization. The sample analyses were performed with
a 90° takeoff angle and spectral peaks were analyzed using the Kratos software.
AFM studies were performed with a commercial instrument (Nanosurf
easyScan 2 equipped with a TFT-LCD display). It was operated by a silicon SPM-sensor
(NanoWorld, Neuchatel, Switzerland) in contact mode with 0.2 N/m spring constant and
13 kHz response frequency. The ammonium-coated detector is 2 pm thick, 450 pm long,
and 50 pm wide. All images were recorded in air at room temperature, at a scan speed of
1.4 Hz. The background slope was resolved using the program provided by the
manufacturer. No further filtering was performed.
Oxalyldihydrazide immobilization within the chip was demonstrated using a
fluorescent analogue, Alexa 488 hydrazide. Alexa 488 hydrazide was loaded as
described above, and fluorescence was detected using an Olympus IX-51 Fluorescence
Microscope with an attached CCD camera. Images were taken using a lOx objective and
500 ms exposure time. Filter settings for FITC was used for image capture.
3.2.8

Protein Capture
Prior to loading the target protein into the channel, the channel was blocked by

loading 75 pL of 2 mg/mL BSA at a rate of 5 pL/min. The BSA solution remained in the

channel for 1 hour and then was pushed out using air. Following the blocking,
0.2 mg/mL o f NDA-labeled oxidized cytochrome c was loaded into the channel for
100 minutes at a rate o f 5 pL/min using a syringe pump. Solution was collected at the
collection reservoir every minute for analysis. After the channel was loaded, the chip
was incubated in the dark for two hours. Protein capture was visualized using
fluorescence microscopy.

For the selective capture study, cytochrome c and TRITC-

BSA were mixed, with concentrations of 0.2 mg/mL and 0.8 mg/mL, respectively, in the
same solution and pushed through the channel at 5 pL/min following BSA blocking.
Solution was collected as described above and analyzed every minute on the
Nanodrop 3300 fluorescence spectrophotometer.
3.2.9

Protein Elution
Proteins were eluted using 10 % formic acid. The channel was filled with formic

acid. Formic acid was loaded at a rate o f 10 pL/min. The channel was incubated in an
oven at 60 °C for 30 minutes. Borate buffer was also heated to 60 °C. After incubation,
the channel was rinsed with borate buffer at a rate of 5 pL/min to collect the proteins.
The rinsing occurred on a hot plate held at a constant 60 °C. The eluted solution was
analyzed every minute.

3.3
3.3.1

Results and Discussion

Protein Characterization
Oxidized BSA absorbance was measured with the well-established DNPH

spectrophotometric assay (Levine et al. 1990). Measuring the absorbance at 370 nm
yielded a carbonyl concentration of 18 nmol/mg protein. Figure 3-5 shows the results o f
the DNPH assay. The results obtained from this study verified the placement of carbonyl
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groups on our model protein for further studies. For experiments within the chip, protein
samples were diluted prior to loading to prevent chip saturation. For XPS and AFM
studies, protein concentrations of 10 mg/mL were used. Concentrations were determined
spectrophotometrically using a Nanodrop 3300 Fluorescence Reader. For cytochrome c,
a large native peak around 400 nm is present, completely covering the carbonyl
absorbance at 370 nm. Therefore, carbonyl content was not quantified for cytochrome c
following the metal-catalyzed oxidation process.
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Figure 3-5: Results o f the DNPH assay for the determination of carbonyl content in
oxidized BSA
3.3.2

Water Contact Angle Measurement
Several techniques were used to verify the surface chemistry. First, UV

modification was confirmed using water contact angle measurements. Carboxyl groups
on the surface of PMMA make the surface more hydrophilic. After exposing a PMMA
sheet to UV treatment for twenty minutes, a contact angle o f 46.0 ± 5.7° (n = 3) was
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observed. This angle was compared to a contact angle of 72.2 ± 7.8° (n = 3) for pristine,
unmodified PMMA. The decrease was not as low as reported values in the literature of
30° for a similar exposure time (Wei et al., 2005), so UV exposure time was increased to
one hour for subsequent experiments. The literature results demonstrate a plateau at
around 40 minutes, so a one hour exposure time was used to generate the expected
results. A one hour exposure time was chosen to compensate for any differences
between the setups o f the two UV systems used in this study and the one used in the
literature study. The difference in the system setup could account for the difference
between surface contact angles after 20 minutes. Figure 3-6 shows the change in water
contact angle on the PMMA coverslip after UV exposure.

f
Figure 3-6: Water contact angle between pristine PMMA (a) and UV-modified PMMA
(b)
3.3.3

Fluorescence Microscopy
To ensure that oxalyldihydrazide would bind to the modified PMMA, a

fluorescent analogue, Alexa 488 hydrazide, was used in chip. This analogue was used
because it has the same functional group as the chosen crosslinker. Alexa 488 hydrazide
was loaded into the closed microchip in the same fashion as described for
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oxalyldihydrazide (detailed in the Methods section). The fluorescence observed in the
channel after a buffer rinse indicated Alexa 488 hydrazide was immobilized on the
surface o f the microchannel. As a control, Alexa 488 hydrazide was incubated in a
similar fashion inside a pristine (unmodified) PMMA microchip. After a buffer rinse, no
fluorescence was observed within the microchannel from the unmodified PMMA. The
observation is shown in Figure 3-7.

500

I

500

Figure 3-7: Fluorescence microscopy images of an unmodified channel (a) and a UVmodified channel (b) after an Alexa 488 hydrazide incubation and rinse
3.3.4

XPS Analysis
XPS studies were conducted on PMMA sheets to verify the chemistry used in the

surface modification procedure. The samples were prepared modularly, so each new
modification built upon the last, as indicated in Figure 3-3. The results o f the XPS study
are shown in Table 3-1. After UV modification, oxygen percentage increased,
demonstrating the loss o f a carbon atom as the methyl group was replaced with a
hydrogen. The value obtained in this step (0% = 26.74) matched reported values in the
literature (0% = 26.28) after one hour UV exposure time (Wei et al., 2005). After
oxalyldihydrazide incubation, an increase in nitrogen was observed, corresponding to the
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attachment o f the hydrazide functionalities. Oxidized BSA was used to demonstrate
protein immobilization on the modified surface of PMMA. Protein incubation shows a
great increase in nitrogen composition. Because the coverslip was rinsed prior to
completing the next step, the nitrogen increase seen here was attributed to BSA
immobilization. BSA is a large protein that contains numerous nitrogen atoms in its
lysine side chains and through its peptide bonds, so the increase in nitrogen content is not
surprising. The presence o f nitrogen after UV exposure can be attributed to leakage o f
nitrogen present in the air into the sample container. Native BSA was used as well to
investigate the results of non-specific binding on the coverslip.

Table 3-1: XPS data for the different surface modifications

Sample

C (at. %)

O(at. % )

N (at. % )

78.78

21.22

0

70.52

26.74

2.74

2.64

71.80

18.94

4.24

3.79

69.97

19.93

10.11

3.51

70.50

17.72

11.78

3.98

Native PMMA
UV-modified
PMMA
Oxalyldihydrazide
crosslinked
PMMA
Oxidized-BSA
immobilized
PMMA
Native-BSA
immobilized
PMMA

3.3.5

c/o
3.71 .

AFM Analysis
PMMA sheets were prepared as indicated in Section 3.2.6. AFM studies were

done to calculate the surface roughness of PMMA following each step o f the process.
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Because additional molecules were being placed on the surface of PMMA, the roughness
was expected to increase. The results are shown in Table 3-2. The increase in roughness
after UV treatment and oxalyldihydrazide immobilization was small, consistent with the
small size o f the molecules placed on the surface. A great increase is observed following
oxidized BSA incubation. Because of the size o f BSA (66 kDa), a large increase such as
this could be expected. A similar increase was observed with native BSA, though not as
large.

Table 3-2: AFM results for the different surface modification stages
Stage

Area Surface Roughness (RMS)

Native PMMA

4.03 nm

UV-modified PMMA

6.41 nm

Oxalyldihydrazide-crosslinked PMMA

9.87 nm

Oxidized BSA-immobilized PMMA

31.5 nm

Native BSA-immobilized PMMA
(Control)

20.5 nm

These experiments were conducted on the PMMA sheets, which were used as
received from Goodfellow. Within the microchip, it is important to consider the effect
that the micromilling process will have on the surface roughness of the microfluidic
channel. Any milling marks present on the mold master will be transferred to the
microfluidic chip, since hot-embossing is a technique capable of replicating structures to
the nanometer range. Over time, the characteristics of the mold master can change, and
introduce inconsistencies in the microstructures. To minimize this problem, a two-fold
strategy was employed. First, because of its excellent machining characteristics, brass
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was used as the mold master. Secondly, the mold master milling was completed using
two steps, removal of the bulk material using a large diameter (500 pm) bit, followed by
use o f a smaller milling bit for the finer structures o f the design.
3.3.6

Protein Capture
NDA-labelled oxidized cytochrome c (0.2 mg/mL) was loaded into the channel

and allowed to incubate for two hours. During the loading process, the solution that
flowed through the channel was collected for spectrophotometric analysis. NDA is a
fluorogenic molecule that is only fluorescent after it has reacted with a primary amine
group. Because we use BSA as a blocking protein for the channel, it is necessary to
remove any unbound NDA prior to loading it into the channel. This removal prevented
any blocking BSA from being labelled with the NDA and altering the results obtained.
The amount o f oxidized cytochrome c captured in the microchip could be quantified
using a Nanodrop 3300 spectrophotometer. Figure 3-8 shows the protein amounts
collected each minute. The total protein mass captured during the continuous injection
period o f 100 minutes is 7.5 pg. The plateau seen in Figure 3-8suggest binding of the
target molecule to the reactive sites on the surface o f the microchannel, allowing for less
binding to occur as more proteins are exposed to the chip, indicating a move toward
saturation. Chip saturation occurs when all the available reactive sites for binding are
consumed on the surface o f the modified PMMA. Protein capture is also demonstrated
qualitatively using fluorescence microscopy. The capture is shown in Figure 3-9.
Capture is expected to be linear throughout the experiment, but the results indicate an
area o f non-linearity at the beginning of the study. A potential explanation for the nonlinearity could be that the chip does not capture proteins during the initial loading phase,
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when the solution is first exposed to the crosslinkers. As the chip becomes filled with
fluid, capture improves because there are not two phases present against the crosslinkers.
In the fluorescence study, while not shown here, there are controls that could be
used to verify the capture o f the targeted proteins. One example would be to compare the
channel following capture to a channel that does not have any proteins inside of it.
Another control would be to not conduct multiple steps o f the surface modification
procedure, such as not doing a UV-modification step or crosslinking with
oxalyldihydrazide, and comparing the fluorescence within the channels.
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Figure 3-8: Cumulative capture o f cytochrome c
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Figure 3-9: Fluorescence microscopy of cytochrome c capture following protein
loading and excess fluid removal
3.3.7

Protein Elution
Formic acid and heat were used to elute the proteins. Fonnic acid breaks

hydrazone bonds when incubated at an elevated temperature (Roe et al., 2007). After
thirty minutes of incubation at 60 °C, the channel was rinsed with borate buffer. Since
the proteins were labelled and injected into the channel using borate buffer, this same
medium was chosen to collect the proteins during elution. The solution was collected
from the microchip and analyzed using the Nanodrop 3300. All the proteins injected into
the channel were eluted within three minutes of continuous injection of borate buffer.
The results are shown in Figure 3-10. The total amount o f protein eluted was 8.5 pg.
When the amount o f protein eluted is compared to the amount determined to be captured,
a cumulative elution efficiency of 113 % is obtained. The cumulative elution efficiency
was calculated as the percentage of proteins eluted from the channel and divided by the
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total amount available for elution. For the data shown in Figure 3-10 as an example, after
one minute, 3.5 pg o f the 7.5 pg captured is eluted, resulting in a cumulative elution
efficiency of 46 %. For each additional minute, the total o f all the proteins eluted are
summed together and divided by the total protein amount available. The additional
proteins found in the elution could have been inside the injection tubing when injection
finished. Because the proteins are allowed to incubate for two hours following injection,
any proteins still in the tubing could diffuse into the chip and react with any available
surface. It is proposed that this action added the additional 1 pg o f protein to the elution,
therefore yielding a cumulative elution efficiency in excess of 100 %.
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Figure 3-10: Protein elution per minute from the microfluidic device
The elution o f the proteins increased the concentration of proteins available from
the original stock solution (0.2 mg/mL). The new concentration, using the 15 pL
required to elute all the proteins, is 0.53 mg/mL, an increase of 265 %.
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3.3.8

Protein Mixture Results
To determine the specificity o f the chip for oxidized proteins, oxidized

cytochrome c, labelled with NDA, was mixed in low abundance (1:4) with TRITC-BSA
and injected into the chip. The results of that study are shown, in Figure 3-11. The chip
was able to capture 40 % o f oxidized proteins over the 100 minute injection period,
whereas only 5 % o f the unoxidized protein was captured. These results show that, even
in low abundance, the chip is highly specific to oxidized proteins. The 5 % capture
observed from the unoxidized protein (TRITC-BSA) could have been the result of some
proteins displacing BSA, which was used to block the chip. The results found for the
non-specific binding was confirmed by loading TRITC-BSA into a modified channel.
These results are seen in Figure 3-12.Without blocking, TRITC-BSA is captured within
the chip; after blocking, the capture is significantly lower. These results support the
reasoning that TRITC-BSA is displacing BSA within the channel and indicate the
necessity of blocking the chip prior to enrichment studies in order to increase the chip’s
discrimination of oxidized and unoxidized proteins.
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■ Oxidized protein
■ Unoxidized Protein

Figure 3-11: Results o f the protein mixture study
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Figure 3-12: Non-specific binding with and without prior blocking of the channel with
BSA
3.3.9

Discussion
The effect of fluid dynamics on the ability of the microchip to capture targets is

an area of future work. Flow rate studies can be used as a variable for optimizing protein
capture efficiency. While a faster flow rate would expose the modified surface to
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additional proteins during the loading process, the effects o f shear stress on the
crosslinker, oxalyldihydrazide, would have to be considered. To date, no studies have
been done on the strength o f the bond formed between oxalyldihydrazide and the
carboxyl-labelled PMMA surface or the hydrazone bond formed with the carbonyl of the
protein. Excessively high flow rate could break the links that capture the target
molecules, but excessively low flow rate will increase the time of the experiment.
Therefore, flow rate needs to be optimized in future work.
Another area of consideration is the interior geometry o f the chip. In this
experiment, we used a low-density micropost interior. For future studies, the density of
the microposts can be altered to determine if capture efficiency has a dependency on the
interior geometry.
The method presented in this chapter has several advantages over the
conventional avidin chromatography technique for carbonylated protein enrichment.
One, there is no need to derivatize samples prior to enrichment for the technique. Even
though the sample was derivatized with fluorogenic agents, it is not necessary if the
device is being used as a preconcentrator. Chromatography requires the sample be
derivatized with biotin, a process that is very time-consuming, including 12 hours for
dialysis to remove unbound hydrazide. The technique presented here takes 4.5 hours
from protein loading to elution. Also, in order to be effective, avidin chromatography
needs at least 2.5 mg o f protein, whereas this technique can enrich any amount of protein.
The use o f a microfluidic chip greatly reduces sample waste and protein elution occurs in
a very small volume, greatly increasing the concentration of low abundance targets.
Chromatography requires a high volume of elution solution, diluting even further an
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already very dilute sample. Also, when the targets are released from the microchip, they
are readily available for future studies, with the carbonyl available for additional labeling
if necessary. In standard affinity chromatography, should the carbonyl need to be
relabeled post-elution, the hydrazone bond between biotin and the carbonyl would need
to be broken.
It is important to consider that the elution procedure for this technique is harsh for
biomacromolecules such as proteins. Because of the increased temperature and acidic
conditions for reversing the bond, the protein being captured will be denatured. In
studies where the proteins are being identified, denaturing the protein will not be a
concern. However, for applications in which the protein’s function needs to be
conserved, this technique may not be the best approach for protein enrichment.

3.4

Conclusions

In this chapter, proof of principle of a microfluidic enrichment technique for
carbonylated proteins using oxalyldihydrazide as an immobilized crosslinker was
presented. The preliminary results shown in this chapter demonstrate that the
methodology is effective at capturing and eluting carbonylated proteins. Based on the
new concentration o f the proteins following elution, the microdevice has a
preconcentration factor o f 2.65. An area of work that remains is optimizing the capture
process. Key areas for optimization include the flow rate at which proteins are injected
into the channel and the effect of density on the capture efficiency of the chip. The
optimization of these conditions, along with two other key variables, will be discussed in
the following chapter.

CHAPTER 4

TECHNIQUE OPTIMIZATION

4.1

Introduction

In Chapter 3, a proof-of-principle microfluidic technique for enriching
carbonylated proteins was demonstrated. Capture, enrichment, and elution could be
achieved using the novel methodology. The procedure is capable of enriching proteins
on the microgram (pg) level, and the sample is eluted at a much higher concentration than
what is possible using the commercial standard. Specificity toward the target of interest
when a mixture o f oxidized and unoxidized proteins was injected into the channel was
also shown. This chapter examines the effects of micropost density inside the
microchannel, concentration of the crosslinker, flow rate, and incubation time of the
crosslinker on capture within the microfluidic platform. It is shown that micropost
density has little effect on capture and that shorter incubation periods result in capture
that is marginally better than longer incubation times. In addition, slower flow rates
result in significantly better capture and protein capture follows a parabolic curve with
crosslinker concentration.
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4.2
4.2.1

Materials and Methods

Materials
PMMA sheets were purchased from Goodfellow. EDTA, HEPES, potassium

chloride, magnesium chloride, sodium ascorbate, iron (III) chloride, and N-(3dimethylaminopropyl)-N-ethylcarbodiimide (EDC) and bovine serum albumin (BSA)
were purchased from Sigma Aldrich (St. Louis, MO). Oxalyldihydrazide was purchased
from Alfa Aesar (Ward Hill, MA). N-hydrosuccinimide (NHS) was purchased from
Thermo Scientific (Rockford, IL). Naphthalne-2, 3-dicarboxaldehyde (NDA) was
purchased from Invitrogen (Eugene, OR). Cytochrome c was purchased from EMD
Chemicals.
4.2.2

Channel Construction
The microchannels were formed using a nickel mold master and hot embossing.

The process is described in detail in the previous chapter. The two microchip designs
used in the study are shown in Figure 4-1. Both channels are 12.5 mm long and 1 mm
wide. The first channel, shown on the left, contains 150 microposts, with a post-to-post
spacing o f 150 pm, measured edge to edge. This channel was used in the studies
discussed last chapter. The second channel, shown on the right, contains 465 posts, with
a post-to-post spacing of 100 pm, measured edge to edge. Following hot embossing, the
PMMA chips and PMMA sheets were washed and dried in an oven at 65 °C overnight.
Following drying, the chip and PMMA coverslips (250 pm thickness) were exposed to
UV light (254 nm, 15 mW/cm ) for one hour to place carboxylic acid residues on the
PMMA surface. The chip and cover sheet were pressed together using 3” x 3” glass
plates and annealed at 97 °C for 30 minutes. PEEK tubing (800 pm diameter) was
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attached to the reservoirs using marine EPOXY. The experimental setup is the same as
shown in Figure 3-2.
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Figure 4-1: The two channel designs used in the optimization experiments. The
channel on the left is the same channel used in the experiments in the last chapter. The
channel on the right has a higher post density. The scale bar is 500 pm
4.2.3

Surface Modification
After the EPOXY was allowed to fully cure, 100 pL of MES buffer containing

200 mM EDC and 50 mM NHS was loaded into the channel using a syringe pump at a
rate of 10 pL/min to activate the carboxylic acid functional groups on the surface of the
PMMA microchip. The PEEK tubing was connected to the syringe pump using a LUER
connector. The solution was allowed to incubate within the channel for 30 minutes.
After incubation, 100 pL o f oxalyldihydrazide, dissolved in MES buffer, was loaded into
the channel at a rate o f 10 pL/min and allowed to incubate. Air was pushed through the
channel after the incubation to remove unbound hydrazide. The channel was filled with
2 mg/mL BSA to block non-specific binding at a rate of 5 pL/min. The BSA was
allowed to incubate for one hour, followed by a 100 pL rinse with 10 mM borate buffer
at a rate o f 10 pL/min. Finally, air was pushed through the channel to remove the borate

64
buffer and the proteins were loaded into the channel. Fresh solutions of EDC/NHS and
oxalyldihydrazide were prepared daily.
4.2.4

Off-chip Protein Labeling
Cytochrome c (5 mg/mL) was oxidized in vitro using metal catalyzed oxidation

(MCO). Oxidized cytochrome c was diluted to 2 mg/mL in 100 % methanol and placed
in freezer until experiments. A stock solution of 5 mM NDA dissolved in methanol was
prepared and stored in refrigerator protected from light. The stock solution was used
within a week. Prior to loading into the channel, proteins were labeled with the
fluorescent tag NDA. 100 pL of oxidized cytochrome c was placed in a small centrifuge
tube. Into the tube was added 400 pL of 10 mM borate buffer (pH 9.3), 100 pL KCN,
and 400 pL of NDA, in that order, giving a total sample volume of 1 mL. The tube was
allowed to incubate for 30 minutes in the dark. Following incubation, the sample was
loaded into an Amicon Ultra-4 centrifugal filter unit (3000 MW cutoff) to remove
unbound NDA. Two rinses occurred in 10 mM borate buffer at a speed of 4500x g for
20 minutes, followed by a final spin down to about 200 pL at the same conditions. The
sample was supplemented to a total volume of 1 mL with 10 mM borate buffer.
Fluorescence measurements using the Nanodrop 3300 photospectrometer were taken to
verify the presence o f the fluorescently-tagged proteins within the sample. The proteins
were then loaded into the channel.
4.2.5

Interior Geometry Studies
Protein capture was measured using the two different interior geometries shown

in Figure 4-1. Proteins were loaded into the channel at a flow rate o f 5 pL/min. Proteins
were loaded through the PEEK tubing and collected at the exit reservoir o f the chip using
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a pipettor. The flowthrough solution was collected every minute and analyzed using the
Nanodrop 3300. Both channels were surface modified on the same day using the same
oxalyldihydrazide, EDC/NHS, and BSA solutions.
4.2.6

Oxalyldihydrazide Concentration Studies
Oxalyldihydrazide concentration was varied to assess its impact on protein

capture. The concentrations used were 5 mM, 10 mM, 25 mM, and 50 mM. The protein
was loaded and collected as described above. The oxalyldihydrazide concentrations were
serially diluted from the same sample of 50 mM. All channels were surface modified on
the same day using the same solutions. Experiments were performed in the lower density
channel shown in Figure 4-1.
4.2.7

Flow Rate Studies
Different flow rates were tested to determine protein capture. The flow rates used

were 5 pL/min, 10 pL/min, and 20 pL/min. The concentration of oxalyldihydrazide was
25 mM. Experiments were completed using the lower density channel shown in Figure
4-1. All channels were surface modified the same day using the same solutions. Proteins
were loaded and collected as described above.
4.2.8

Oxalyldihydrazide Incubation Studies
Incubation time for oxalyldihydrazide following chip loading was varied to

determine protein capture. The incubation times chosen were 1 hour, 4 hour, and
overnight (16 hours). The protein loading flow rate was 5 pL/min. All other conditions
from the flow rate study were applied.
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4.2.9

Statistics
For data collected from the flow rate and crosslinker incubation time experiments,

a two-tailed, equal variance Student’s t-test was used for statistical analysis with a
p < 0.05 being considered statistically significant.

4.3
4.3.1

Results

Interior Geometry Studies
Interior geometry o f the microfluidic chip was varied to investigate the effects on

protein capture. Figure 4-2 shows the results o f these studies. After 40 minutes of
continuous protein flow, both channels capture about 5 pg of proteins. The capture
occurs at a steadier rate using the lower density channels, whereas the higher density
channels begin to capture later, but over time achieve equality with the lower density
channel.
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Figure 4-2: Results of the interior geometry studies
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4.3.2

Oxalyldihydrazide Concentration Studies
The effects of oxalyldihydrazide concentration on protein capture were studied.

The results are shown in Figure 4-3. The highest capture is observed at an
oxalyldihydrazide concentration o f 25 mM. Both 5 mM and 10 mM resulted in lower
capture, while using 50 mM resulted in the lowest capture efficiency. After 40 minutes,
both 5 mM and 50 mM are decreasing their positive slope, suggesting a move toward
saturation, whereas 10 mM and 25 mM are still increasing.

♦ 5 m M oxalyldihydrazide
concentration
A 10 mM ox alyldihy drazide
concentration
• 25 mM oxalyldihydrazide
concentration
■ 50 mM oxalyldihydrazide
concentration
10

20
Time {min)

30

Figure 4-3: Results of the oxalyldihydrazide concentration studies
4.3.3

Flow Rate Studies
Protein capture for different flow rates is shown in Figure 4-4. Each channel had

the same mass o f proteins (40 pg) injected into it. Protein capture per minute was
normalized to allow for easier comparison. The highest normalized capture occurs at
5 pL/min. Capture decreases with each faster flow rate. Capture is significantly higher
under 5 pL/min flow vs. the other two flow rates (10 and 20 pL/min: p = 5.8 x 10'7 and
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7.67 x 10'5, respectively), whereas a significant difference was not observed between the
10 and 20 pL/min flow rates.

■ 5 ul/min
■ 10 ul/min
■ 20 ul/min

Figure 4-4: Protein capture as a function of flow rate. The bars represent the average
normalized protein capture with bars representing a 95 % confidence interval (mean ±
95 % Cl)
4.3.4

Oxalyldihydrazide Incubation Time Studies
Lastly, oxalyldihydrazide incubation times were varied to enhance protein

capture. The results are shown in Figure 4-5. As with flow rate, protein capture per
minute is normalized to allow for comparison between the groups. Capture efficiency
was slightly lower for the larger oxalyldihydrazide incubation times, but the results were
not statistically significant between the groups.
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■ 1 hour
■ 4 hour
■ Overnight (16 hour)

Figure 4-5: Results o f the oxalyldihydrazide incubation studies

4.4

Discussion

It was expected that additional microposts would increase the surface area for
hydrazide modification and therefore, protein capture. However, it was observed that
capture was not enhanced in a higher density channel. It is suspected that the capture is
not different because of the way UV light is exposed to the chip. The chip is directly
underneath the UV light source when carboxylic acid groups are placed on the surface.
The posts are parallel to the UV light source; therefore, the sides o f the posts are not
exposed to UV light. This lack of exposure prevents carboxylic acid groups from being
generated there. Therefore, the area available to capture proteins is completely dependent
upon the area o f the floor o f the channel and the coverslip above the channel (Figure 4-6).
The two designs do not differ much in this available area, so it is not surprising to see
such a result. Because the amount of capture was similar between the two channels, the
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lower density channel was used for future experiments because it had a smaller pressure
drop. A potential method for overcoming the lack o f exposure for the sides o f the
microposts would be to use fiber optics. The sides o f the posts could be modified by
shining a UV fiber optic parallel to the walls o f the channel and perpendicular to the
microposts. This approach, while not allowing for total activation o f the sides o f the
posts, would increase the amount of UV activation on the posts compared to the current
UV exposure technique.

COOH G ro u p

UV

Sourer

LI J

Figure 4-6: Approach o f UV light to the microchip makes activation of the sides o f the
microposts difficult
For the proof-of-principle studies detailed in the previous chapter, an
oxalyldihydrazide concentration of 50 mM was used. The concentration of
oxalyldihydrazide was varied in order to determine whether reagent usage could be
optimized within the enrichment protocol. The results show that an oxalyldihydrazide
concentration o f 25 mM was optimal for protein capture. The observation that both
5 mM and 10 mM concentrations of oxalyldihydrazide had higher capture efficiency than
a 50 mM concentration was unexpected. Upon further investigation, it is seen that
oxalyldihydrazide is supersaturated at a concentration of 50 mM when dissolved in MES
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buffer. This is the only concentration at which it is not completely dissolved in solution.
The undissolved oxalyldihydrazide may interfere with the binding capacity o f the chip.
This interference could occur as undissolved hydrazide settles onto carboxylic acid
residues, but does not react with the functional group. These particles are pushed out
during the evacuation step, leaving unreacted carboxylic acid groups which are then
blocked with BSA. This process would reduce the capture ability o f the chip. The
parabolic capture curve seen from the oxalyldihydrazide studies support this hypothesis,
shown in Figure 4-7.
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Figure 4-7: Parabolic nature of protein capture in relation to the concentration of
oxalyldihydrazide
For the flow rate experiments, it was decided that the best approach would be to
inject the same amount of mass into each channel. This approach would prevent a mass
bias from being introduced into the experiment, where additional proteins are captured at
faster flow rates because an additional amount o f protein mass flows into the channel.
This scenario would have been the case if each flow rate was allowed to be injected for
the same amount o f time. Additionally, by using normalized protein capture per minute

in the data analysis, the potential for mass bias was prevented even further. Protein
capture was normalized by dividing the fluorescence value obtained from the solution
collected at the collection reservoir by the fluorescence value collected from the original
sample prior to loading it into the chip. Normalized protein capture differed significantly
between the lower flow rate and the other flow rates used in the study. The greater
capture is attributed to the targets being in contact with the sample for a longer period of
time. This increase in contact time would result in a higher chance of the bond being
formed, and thus, a better capture efficiency. Indeed, when cell capture studies were
completed inside a microfluidic channel, a similar phenomenon was observed, as capture
increased linearly with the amount of time the cells were allowed to remain in contact
with the aptamers (Phillips et al., 2009). Another study looked at microfluidic negative
enrichment of target cells. Their results demonstrated higher sample purity at lower flow
rates, indicating that lower flow rates result in higher capture in microfluidic
environments (Li et al., 2011). The difference between the 10 and 20 pL/min flow rates
was not significant. However, it is believed that the difference would have been
significant if the 20 pL/min flow rate had more samples. An increase in sample points
would have allowed the data to be in closer agreement with the central limit theorem’s
minimum requirements.
An effort was made to prevent a mass bias in this study by loading the same mass
o f proteins through the chip. If all studies were conducted for the same amount of time,
the expectation that lower flow rates would result in higher mass capture would be
counter-intuitive. One would tend to expect a higher capture at faster flow rates because
of the increased mass exposed to the functionalized surface.
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The results also lead to the possibility o f a misconception being formed
concerning protein capture. Based on the results seen here, it would be expected that as
the flow rate moves slower, the capture efficiency would proceed to 100 %. However,
protein stability needs to be considered. Slower flow rates would result in longer
experimental times. Increasing experimental time also increases the likelihood of the
protein becoming more labile. Also, the detection methodology used in these studies,
fluorescence, is sensitive to time as well. Therefore, the longer the experiment occurs,
the less observable the fluorescence intensity becomes. As fluorescence intensity
decreases, overestimation o f the protein capture within the microchannel would occur.
Lastly, a study on the amount of time oxalyldihydrazide was incubated inside the
channel was completed. The purpose of this study was to determine if shorter
incubations had a negative effect on protein capture. In previous studies,
oxalyldihydrazide was allowed to incubate overnight. This study was conducted to
determine if the total time for enrichment could be reduced. It was seen that a reduction
in incubation time resulted in a slight increase in capture efficiency. However, the
increase is not statistically significant. In fact, the cumulative capture percentage
difference between a one hour incubation and an overnight incubation is roughly 3 %, or
3 pg per 100 pg of proteins injected. When taking into account that the system’s dead
volume can easily contain 3 pg, this difference is statistically insignificant. However,
lack of statistical significance does not imply the data is not meaningful. On the contrary,
these results allow for time optimization of the enrichment protocol, as it is now known
that the chip is ready for capture after only one hour o f oxalyldihydrazide incubation.
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4.5

Conclusions

In this chapter, a series o f experiments were presented with the intention of
optimizing protein capture using the microfluidic technique. Micropost density and
oxalyldihydrazide incubation time only marginally affected protein capture.
Oxalyldihydrazide concentration and flow rate significantly affected capture efficiency.
Following the optimization studies, sample size, perfusion time, and reagent consumption
were reduced. A critical consideration of the methodology is the determination of the
point-of-failure. In particular, it is important to analyze the conditions at which the chip
would not be effective at enriching the target carbonylated proteins. The theoretical
modeling for this determination is discussed in the next chapter.

CHAPTER 5

MODELING THE POINT OF FAILURE

5.1

Introduction

In Chapter 3, a novel microfluidic enrichment technique was developed for the
capture, enrichment, and elution of carbonylated proteins. The technique had a
preconcentration factor o f 265 %. In Chapter 4, progress continued on making this
technique an attractive alternative to the commercially available avidin chromatography
technique currently considered the gold standard in enrichment technology. Four
variables were studied for optimization of the process. The optimization of the process
resulted in a reduction o f sample, reagent, and time requirements.
It is important to determine experimental conditions that would cause the
technique to fail. Failure is defined in this sense as conditions that would result in
reduced ability for the methodology to enrich carbonylated proteins. In this chapter,
theoretical modeling is used to analyze experimental conditions that would result in
failure. Density functional theory is used to determine the binding energies of the
oxalyldihydrazide molecule to both the UV-modified PMMA and to the amino acid
residues lysine, proline, arginine, and threonine. Cytochrome c is used as the protein
model for protein capture. The results obtained from density functional theory allow for
the calculation of a critical force. This critical force is used in Stokes’ law to determine a
critical velocity for proteins. Based on these calculations, the experimental conditions
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leading to failure are identified. It is seen from the results that failure o f the microfluidic
device will most likely not be a result of the bonds breaking, as the critical velocities
calculated are not feasible within a microfluidic environment.

5.2
5.2.1

Methods

Chip Dimensions
The microchannels were formed using a nickel mold master and hot embossing.

The process is described in Chapter 3. The microchannels used for modeling were
described in Chapter 4. Refer to Figure 4-1. Both channels are 12.5 mm long and 1 mm
wide. The first channel, shown on the left, contains 150 microposts, with a post-to-post
spacing o f 150 pm, measured edge to edge. The post diameter is 100 pm and the depth
of the microchannel is 50 pm. The total area available for capture is 27.6 mm2. The
second channel, shown on the right, contains 465 posts, with a post-to-post spacing of
100 pm, measured edge to edge. The post diameter is 70 pm and the depth of the
microchannel is 35 pm. The total area available for capture is 26.4 mm2.
5.2.2

Reaction Scheme and Model Assumptions
The purpose of this study is to model the reaction shown in Figure 3-3 inside the

microchannels. First, the microchip is exposed to UV radiation, carbonizing the pristine
PMMA. The carbonization places carboxylic acid functional groups on the surface of the
channel. Then, the carboxylic acid residues are activated using a mixture o f EDC and
NHS, followed by exposure to oxalyldihydrazide (Figure 2-5) to immobilize the
crosslinker to the microchannel surface. Lastly, proteins are injected into the channel.
These proteins are captured by the immobilized oxalyldihydrazide molecules. In this
chapter, four different oxalyldihydrazide concentrations are modeled: 5 mM, 10 mM,

25 mM, and 50 mM. These concentrations are the same as were used experimentally in
Chapter 4.
The model protein used is cytochrome c. Cytochrome c is a highly conserved
protein among many species. The particular molecule used in this paper is equine horse
heart cytochrome c. It has 104 amino acid residues. It is a membrane associated protein.
In vivo, it is spherical in shape with a radius of 1.2 nm (Choi and Dimitriadis, 2004).
For the model presented in this paper, certain assumptions are used. These
assumptions are the following:
1. All PMMA monomers are carbonized during the UV exposure step.
2. The monomers have a 1:1 reaction with oxalyldihydrazide molecules.
3. Oxalyldihydrazide molecules can only react with one UV activated
PMMA monomer. That is, the molecule cannot bind so that two
monomers are consumed by the two hydrazide functional groups on one
oxalyldihydrazide molecule.
4. When oxalyldihydrazide is immobilized on the surface of the
microchannel, it is immobilized with an even distribution across the unit
cell. This assumption prevents the model from allowing an area o f an
unsaturated unit cell from being capable of more protein capture than any
other area o f the unit cell.
5. No capture occurs during loading; all capture occurs during the incubation

5.3
5.3.1

Results and Discussion

PMMA Unit Cell and Oxalyldihydrazide Approximation.
A PMMA unit cell approximation was used for modeling the molecular

interactions within our microdevice. The PMMA unit cell is 4.196 nm wide, 2.434 nm
long, and 1.05 nm deep, determined from experimental data (Sane et al., 2002). The unit
cell contains 150 monomers of the PMMA polymer, arranged in 3 chains of
50 monomers each. There are a total of 2250 atoms per cell. The unit cell is shown in
Figure 5-1. There are a total of 3.08 x 1012 and 3.04 x 1012 PMMA unit cells in the lower
and higher density microchannel, respectively. Therefore, there are a total of 4.63 x 1014
and 4.56 x 1014 PMMA monomers inside each microchannel, respectively. Using the
sidearm o f the PMMA molecule as a base, the length of the oxalyldihydrazide molecule
was estimated to be 2.1 nm, based on the molecule having twice as many similarly-sized
atoms (Figure 2-5). The capture cells within the microchannel are 4.196 nm wide,
2.434 nm long, and 3.15 nm deep, accounting for capture o f oxalyldihydrazide within
3.15 nm of the channel surface for the model. The capture cell is shown in Figure 5-2.
The entire channel was divided into equal sized capture cells, with only the cells in
contact with the wall surface being capable of oxalyldihydrazide and/or protein capture.
There are a total o f 3.02 x 10!6 and 2.11 x 1016 total cells in the low density and high
density channels, respectively. Figure 5-3 shows a representation of the cells, with the
cells capable of capture shown in green.
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Figure 5-1: A schematic of a PMMA unit cell

3.1 nm

4.2 nm
Figure 5-2: Dimensions of the capture cells used in modeling oxalyldihydrazide and
cytochrome c capture

Figure 5-3: Representation of the arrangement o f capture cells within the microfluidic
device
Four concentrations o f oxalyldihydrazide were used in the model. At these
concentrations, the number o f oxalyldihydrazide molecules present within a volume o f a
capture cell (32.1 yL) was 67, 134, 334, and 668 for the four concentrations, respectively,
in the lower density channel. For the higher density channel, the number of
oxalyldihydrazide molecules was 45, 90, 224, and 448, respectively. These values were
compared to the available PMMA monomers for reaction (150 monomers) in each
condition. The results are shown in Figure 5-4.
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Figure 5-4: Ratio of PMMA to oxalyldihydrazide molecules at the four different
concentrations o f oxalyldihydrazide
By using a ratiometric approach in the analysis, it is easier to determine full
saturation o f the PMMA monomers. Ideally, a concentration that results in an equal
number o f oxalyldihydrazide to PMMA monomers would be desirable. Above that point,
as seen in the 5 mM and 10 mM concentrations in both densities, there are unreacted
PMMA molecules, and the efficiency of the protein capture will not be optimized. Below
that point, as observed at 25 mM and 50 mM, excessive oxalyldihydrazide will compete
with bound oxalyldihydrazide for the limited number of PMMA monomers. Therefore,
once the ratio o f PMMA molecules to oxalyldihydrazide molecules decreases below 1,
reagent usage is no longer optimized.
5.3.2

Binding Energies from DFT
Using DFT, the binding energy between UV activated PMMA and

oxalyldihydrazide and between oxalyldihydrazide and the four amino acid residues was

determined, according to the reaction scheme seen in Figure 3-3. The binding energy for
oxalyldihydrazide and UV activated PMMA was -4.47 kcal/mol. The binding energies
for oxalyldihydrazide reacting with proline, lysine, arginine, and threonine, respectively,
was -3.06 kcal/mol, -4.00 kcal/mol, -7.80 kcal/mol, and -5.43 kcal/mol. The binding
energies are presented in Table 5-1.

Table 5-1: Binding energies for PMMA and amino acid residues to oxalyldihydrazide

5.3.3

Phase

Binding Energy (kcal/mol)

UV-PMMA to oxalyldihydrazide

-4.47

Oxalyldihydrazide to proline

-3.06

Oxalyldihydrazide to lysine

-4.00

Oxalyldihydrazide to threonine

-5.43

Oxalyldihydrazide to arginine

-7.80

Protein Binding
In this model, oxidized equine horse heart cytochrome c was used as the target

protein o f interest. Cytochrome c is a highly-conserved protein throughout many
organisms. It is a spherical protein, with a radius of 1.2 nm, giving it an area o f 4.52 nm2.
Using this value, 2.2 cytochrome c molecules can attach per unit cell of PMMA. Each
cytochrome c molecule will occupy the space o f 66 PMMA monomers. At the
concentrations used in this model, per cytochrome c surface area, there will be
27 oxalyldihydrazide molecules bound at 5 mM, 57 at 10 mM, and 66 at both 25 mM and
50 mM within the lower density channel. For the higher density channel, the number of
oxalyldihydrazide molecules is 18, 39, 66, and 66 for each concentration, respectively.
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The oxalyldihydrazide consumption is shown in Figure 5-5. It is assumed in this case
that after the ratio of PMMA to oxalyldihydrazide molecules decreases below one, the
PMMA unit cell becomes saturated, and as such, all possible PMMA binding sites are
occupied with an oxalyldihydrazide molecule.
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Figure 5-5: Oxalyldihydrazide molecules per cytochrome c surface area
These values were used to calculate the number of protein molecules captured
within the chip. For each concentration, a molecule of cytochrome c consumes the
number o f oxalyldihydrazide molecules determined above. Those values were used to
determine the maximum number of carbonylated proteins that could be enriched in each
condition. For the lower density channel, 3.12 x 1012, 6.23 x 1012, 7.00 x 1012, and
7.00 x 10^ proteins could be captured for each concentration, respectively. For the
higher density channel, 2.06 x 1012, 4.22 x 1012, 6.91 x 1012, and 6.91 x 1012 proteins
could be captured for each concentration, respectively. The results are shown in Figure
5-6.
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Figure 5-6: Number o f proteins captured for each oxalyldihydrazide concentration
After the number o f proteins captured was determined, this number was converted
to a mass. Compared to experimental values found in Chapter 4, the model
underestimated the experimentally measured values by almost two orders of magnitude.
The values found using the model and the experimental findings are shown in Table 5-2.

Table 5-2: Comparison o f experimental protein capture to predicted capture by the
model

Concentration

Model Results
(Mg)

Experimental
Results (pg)

Model Results
(Mg)

Experimental
Results (pg)

5 mM

0.06

6.73

0.04

N/A

10 mM

0.12

8.79

0.08

N/A

25 mM

0.14

9.79

0.14

N/A

50 mM

0.14

5.01

0.14

5.18
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The model underestimated the protein capture because it only considered the
interior o f the microchannel. In order to improve upon these results, the model was
adjusted to also include the surface area of the reservoirs. Including the reservoirs
significantly increased the total surface area available for protein capture. Because the
majority o f the experimental data collected in Chapter 4 is for the lower density channel,
the reservoir consideration was applied to the results of the lower density channel. The
protein capture for the model’s adjustment is compared to the original model’s results in
Figure 5-9.
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Figure 5-7: Comparison o f protein capture when reservoirs are considered
These protein values were converted to a mass quantity. The model still
underestimated the amount of proteins found in experimental conditions, but the
consideration o f the surface area contributed by the reservoirs produced a significant
improvement from the original model’s results. Table 5-3 shows the comparison of the
protein mass using the new adjustment and the experimental results found in Chapter 4.
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Table 5-3: Comparison o f model results to experimental results when the reservoirs are
considered

5 mM

Model Results
(PR)
0.21

Experimental
Results (pg)
6.73

10 mM

0.42

8.79

20.9

25 mM

0.47

9.79

20.8

50 mM

0.47

5.01

10.6

Concentration

Fold difference
32.0

It is important to consider that volume would be expected to have an impact on
the protein capture. The PMMA unit cell and the capture cell used in this model have a
set volume (see Figure 5-2). However, the PMMA unit cell is only present on the
surface of the microchip (Figure 5-3). Therefore, if the volume of the microchip is
decreased, more oxalyldihydrazide and proteins would be present within each capture
cell. The higher concentration o f crosslinker and proteins would result in higher capture
within the microchannel. The lack o f a volume consideration probably contributes to the
underestimation o f the model.
This particular protein has 104 amino acid residues. O f those, there are four
proline residues, eighteen lysine residues, two arginine residues, and nine threonine
residues, for a total o f 33 possible carbonylation sites. A binding energy of 4.51 kcal/mol per binding site is calculated from the weighted average of these residues.
Because it is impossible to calculate which residue is reacting with the oxalyldihydrazide
molecule at each point, it is important to consider a weighted average o f the amino acid
residues to get the best approximation. The total binding energy between cytochrome c
and the oxalyldihydrazide-immobilized PMMA unit cell is 121.7 kcal/mol,

256.8 kcal/mol, 297.4 kcal/mol, and 297.4 kcal/mol, respectively, for the different
concentrations within the lower density channel. For the higher density channel, the total
binding energy for the different concentrations are 81.1 kcal/mol, 175.7 kcal/mol,
297.4 kcal/mol, and 297.4 kcal/mol, respectively. The results of this study are shown in
Figure 5-8.
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Figure 5-8: Energy requirements to break the bond between cytochrome c and
oxalyldihydrazide at the different oxalyldihydrazide concentrations
The presence o f 33 possible binding sites on cytochrome c limits the model. The
model assumes that every oxalyldihydrazide molecule will bind with cytochrome c. At
full saturation (25 mM and 50 mM), there are 66 immobilized oxalyldihydrazide
molecules per cytochrome c surface area. If all possible binding sites on cytochrome c are
considered, then full saturation occurs at a concentration of oxalyldihydrazide that is
below 10 mM. However, steric hindrance would prevent additional protein capture
inside the microchip. It is important to consider this steric hindrance as it will alter the
binding energy between cytochrome c and the oxalyldihydrazide-immobilized PMMA
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unit cell. This consideration changes the binding energies in the lower density channel to
121.6 kcal/mol at 5 mM and to 148.7 kcal/mol for the 10 mM, 25 mM, and 50 mM
concentrations. The higher density channel has a binding energy of 81.1 kcal/mol at
5 mM and 148.7 kcal/mol for the other concentrations. These results are compared to the
results that the model gave us in Figure 5-9.
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Figure 5-9: Comparison of the model’s results and the site-limited results
The results here imply a significant change in capture efficiency based on protein
size. Cytochrome c is a small protein, around 12 kDa. Other proteins are much larger,
such as bovine serum albumin (BSA), at around 66 kDa. In addition, BSA contains over
600 amino acid residues, compared to cytochrome c’s 104 residues. With increased size,
the amount of binding with immobilized oxalyldihydrazide molecules would increase.
Therefore, the binding energy would be higher for larger proteins as there would be more
amino acid binding residues. However, the tradeoff in this case would be the limited
space inside the microchip. Therefore, higher binding energy could be achieved in
exchange for fewer proteins captured within the microchannel.
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5.3.4

Critical Velocity Calculations
Lastly, Stokes’ Law was used to determine a critical velocity at which these bonds

between oxalyldihydrazide and the amino acid residues would be broken. First, the
critical force had to be determined for the oxalyldihydrazide and the cytochrome c
binding site. This value was calculated to be 6.28 x 10‘6dynes. The calculation is
included in this dissertation, beginning with Eq. 5-1:
E
f c = 1.6 X 10‘ 5 - .
ro

Eq. 5-1

The E0 value corresponding to a binding energy of 8.5 kcal/mole, the typical
strength o f an antibody-antigen interaction, is 0.37 eV. Because electron-volts are a
linear unit, the weighted average binding strength o f a binding site on cytochrome c
(4.51 kcal/mol) correlates to an E0 value of 0.19 eV. As given by Bell (1978), a good
approximation of r0 is 0.5 nm. Therefore, the calculation continues as follows:
f c = 1.6 x 1 0 "5 x

Eq. 5-2

The calculation yields the result/c = 6.28 x 10-6 dynes per bond. This value
was applied to Stokes’ Law to determine the critical velocity. Because the proteins will
be delivered in a buffer solution, the viscosity chosen for the calculation is the kinematic
viscosity o f water at 20 °C (1.002 cP). Using the critical force, a critical velocity of
74.8 m/s at 5 mM and 91.5 m/s at all the other concentrations was obtained for the lower
density channel. This velocity would be required in order to completely remove the
protein from the oxalyldihydrazide molecules tethered to the lower density microchannel
surface.
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The calculation for the 5 mM concentration will be shown below for an example,
starting with Stokes’ Law (Eq. 5-3):
F = 6nr}rv.

Eq. 5-3

First, the total critical force for removing the cytochrome c completely from the
oxalyldihydrazide molecules immobilizing it is calculated. This value is found by
multiplying the critical force for each bond by the number of bonds immobilizing the
protein, shown in Eq. 5-4:
Fc = fcNrA c.

Eq. 5-4

NrA c is thenumber of oxalyldihydrazide molecules per cytochromec surface
area. For 5mM, NrAc = 27, as calculated in an earlier section (see Figure 5-5). The
product o f the critical force, calculated from Eq. 5-2, and NrA c, yields a total critical
force o f Fc = 1.70 x 10-4 dynes.
Because all of the terms in Stokes’ Law are independent of velocity, substituting
the total critical force into Eq. 5-3 yields Eq. 5-5:
Fc = 6nr}rvc.

Eq. 5-5

Solving for the unknown value, vc, the following calculation can be done:
(1.70
Vc

x

1Q-4)(1 Q -5)

6tt(1.002)(1.2 x 10~9)'

q'

This calculation gives a critical velocity o f vc = 74.8 m /s . For the higher density
channel, the critical velocities are 49.9 m/s at the 5 mM concentration and 91.5 m/s at all
the other concentrations. The values used for the calculations are shown in Table 5-4.
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Table 5-4: Variables used in critical velocity calculations
Variable
Eo
ro
r
9

Definition
The free energy change on
binding
The range of the minimum
work
The radius of the binding
target
The viscosity o f the
flowing solution

Value
0.19 eV
0.5 nm
1.2 nm
1.002 cp

One o f the assumptions o f this model is that every binding site on the protein can
and does react with the immobilized oxalyldihydrazide molecules. However, because the
protein is spherical, it is highly likely that this assumption would not hold in reality.
Many o f the binding sites probably are not in contact with the oxalyldihydrazide
molecule area. Therefore, the number of bonds per protein would be lower than the
33 bonds it is capable o f forming. The fewer the bonds, the lower the critical velocity
would be to break the bonds. In addition, if more of the bonds are formed using proline
residues, the binding energy will be lower. Conversely, more bonds with threonine
residues will result in a higher binding energy. Figure 5-10 shows the range of binding
energy possible for cytochrome c based upon the number o f bonds formed. Two ways to
increase the probability o f forming more bonds between cytochrome c and the
oxalyldihydrazide molecules experimentally would be to reduce the disulfide bonds of
cystine, which would break some of the turns of the spherical protein, and denaturing the
protein using heat and/or extreme pH conditions. However, such an approach would
have a tradeoff as the denatured protein would consume a larger area. Therefore, higher
binding energy would be possible at the expense of fewer proteins being captured.
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Figure 5-10: The maximum and minimum binding energies possible based on the
number of bonds formed
Using the least favorable conditions for binding energy (1 proline residue bond
formed), a critical velocity for breaking this bond would be 1.88 m/s, a 1000-fold higher
than experimental loading conditions. In a microfluidic environment, the likelihood o f
the bonds breaking because they exceed the critical velocity is low. At the rates
necessary to break the bonds, even at the least favorable condition, the pressure drop
within the microchannel would be insurmountable. Therefore, microdevice failure is
more likely to be caused by the breaking o f a seal than by the breaking o f the bonds
breaking inside the channels.

5.4

Conclusions

In this chapter, a theoretical modeling approach geared toward optimizing
enrichment of carbonylated proteins within a microfluidic device was presented. Two
interior chip geometries were used. The model generated the binding energy between
oxalyldihydrazide and PMMA, as well as the binding energy between oxalyldihydrazide

and select amino acid residues. A total binding energy of cytochrome c with the
immobilized oxalyldihydrazide molecules was found. Lastly, Stokes’ law was used to
calculate the critical velocity that would result in the breaking of the chemical bonds. It
was determined theoretically that flow conditions will not cause the microfluidic
enrichment technique to fail, as the flow velocities needed to dissociate the bonds exceed
feasible flow velocities within a microdevice.
The model provides guidance toward the optimization of the novel enrichment
methodology. However, the model has a few limitations. The assumptions o f the model
represent an ideal environment. The model does not consider reactions that occur during
protein loading. Lastly, when the number of proteins captured is converted to a mass
quantity, it was found that the model underestimated the experimentally determined mass
in Chapter 4 by over an order of magnitude. In the next chapter, suggestions for
improving the model will be discussed.

CHAPTER 6

CONCLUSIONS AND FUTURE WORK

6.1

Conclusions

The development of a novel enrichment technology for carbonylated proteins has
been discussed. Advantages of using this system to the conventional technique o f affinity
column chromatography include reduced sample consumption, reduced time, and
minimized sample preparation steps. These advantages are outlined in Table 6-1.
Because the process is done on a microfluidic platform, experiments can easily be nm in
parallel in order to achieve high-throughput protein analysis. When proteins are eluted
from this system, they are readily available for additional analysis, such as mass
spectroscopy or electrophoresis. Because samples do not require derivatization prior to
loading into the microchip, no additional considerations, such as molecular weight shift,
need to be taken when the samples are analyzed further.
This microfluidic technique is used for positive enrichment of carbonylated
proteins. The technique could also be used for negative enrichment o f carbonylated
proteins; in case these low abundance proteins are not desirable in a sample o f interest.
In addition, because of the ease o f modifying the surface of PMMA, the technique can be
modified for analyzing other protein modifications present in diseased state tissue. An
important feature o f this process is its versatility. While oxalyldihydrazide was used in
this study for carbonylated protein enrichment, other crosslinkers can be used for other
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post-translational modifications. Because o f its versatility, the technique has potential for
applications in both basic and clinical sciences.
The microfluidic enrichment technique provides a promising platform for
carbonylated protein biomarker discovery in conditions where carbonylated proteins have
been implicated. This device can provide a stepping stone in the development o f novel
diagnostic technologies making use o f biomarkers. It has the ability to be at the forefront
o f quantitative biomarker discovery in conditions such as Alzheimer’s Disease, ALS, and
other neurodegenerative diseases. The technique is an attractive alternative to the
conventionally used avidin affinity chromatography. Because it is microfluidic-based, it
consumes little benchtop space. The technique can provide the building blocks for a
clinically-translatable technology that can yield a quick result on the diagnosis of
neurodegenerative diseases. The process is highly automated, therefore little training
would be required on the part of a clinician to use it and get a result. In addition, because
it is polymer-based, it is disposable and reduces the chance for cross-contamination
between samples. The high versatility of the technique grants a wide range of
applications in both basic and clinical sciences.
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Table 6-1: Comparison between the enrichment technology in different phases and
avidin affinity chromatography

Category

Phase 1
Enrichment

Phase 2
Enrichment

Avidin Affinity
Chromatography

Time Requirement

20 hours

4.5 hours

18 hours

Sample
Requirement

100 pg

40 pg

10 mg

Reagent
Requirement

50 mM crosslinker
for immobilization

25 mM crosslinker
for immobilization

Already packaged,
not determinable

Elution Volume

15 pL

15 pL

4 column volumes
(> 12 mL)

Minimum sample
size

> 1 Mg

> 1 Mg

>4mL

Need for
Derivatization

No

No

Yes

6.2
6.2.1

Future Work

High-throughput Chip Design
The technique discussed in this dissertation produced a preconcentration factor of

2.65. This number depends on the concentration of proteins in a sample. In a clinical
sample, where concentration is much lower than our experimental conditions, the
preconcentration factor will be greatly enhanced. However, the chip design would need
to be changed to allow for high-throughput analysis. Without such an adjustment, the
time advantages offered by the technique would be sacrificed. A simple change to the
design that would increase its high-throughput abilities would be to place numerous
channels on a chip, allowing for a sample to be run in parallel.
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6.2.2

Enrichment o f Multiple Proteins on a Single Microfluidic Device
Since the capture process has been optimized, future directions involve studying

the enrichment behavior o f the chip when multiple carbonylated proteins are present. In
all the studies discussed in this dissertation, only one carbonylated protein has been
present in a sample. However, as discussed in Chapter 5, the binding characteristics o f
proteins vary greatly depending upon their size and amino acid sequence. Therefore, it
would be important to analyze the capture ability of the device when using multiple
carbonylated proteins within one sample. A good approach to this analysis would be the
use o f protein standards o f different sizes. The proteins could be labeled with different
fluorescent tags, and capture could be analyzed using the methods described in this
dissertation. However, a better approach may be to couple the microchip to a standard
benchtop analytical technique, such as capillary electrophoresis, to determine the
technique’s ability to enrich multiple carbonylated proteins. While this approach lacks
the quantitative ability o f the fluorescence approach used in this dissertation, the
experiment will be less costly because each protein in the sample could be derivatized
with the same fluorophore. To use the fluorescence technique described in this
dissertation, each protein in the sample would require the use of a unique fluorophore.
The fluorophores would need to have similar excitation wavelengths, but different
emission wavelengths. However, excitation and emission wavelengths tend to be
correlated for different fluorophores. For example, few fluorescence agents absorb at
488 nm and emit at a wavelength other than 514 nm. If each fluorescent tag were probed
at a different time point, valuable data could be lost and interpolation would be required,
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reducing the reliability o f the data. Therefore, coupling the microchip to a technique like
electrophoresis will yield more reliable results, with a decreased quantitative ability.
6.2.3Use o f a Biological Sample on the Microdevice
In addition, biological samples need to be examined in future work. Such a
sample would be the most complicated sample tested on the microchip. However, the
true power o f the technique will only be seen when a biological sample is used. As an
example, brain tissue could be homogenized, redissolved in a buffer, and then introduced
into the microdevice, to determine whether the carbonylated proteins are detected. For
this study, the proteins would not be labeled with fluorescent agents. Post-elution, the
sample would be passed to another analytical technique to identify and detect protein
targets.
6.2.4

Coupling the Microdevice for Protein Identification
The microfluidic enrichment technique, as developed, was never intended to be a

stand-alone device in its current form. Figure 6-1 shows the modular approach toward
protein enrichment, detection, and identification. As can be seen, the microfluidic
enrichment technique is only a first step in the process. The microdevice will need to be
coupled with a technique for identification of targets. Good candidates for coupling
include capillary electrophoresis (conventional or microfluidic) or mass spectroscopy.
Capillary electrophoresis is more promising as a coupling technology than traditional gel
electrophoresis because it possesses some quantitative aspects. Capillary electrophoresis
is a technique used for separating analytes within a solution (Feng et al., 2008). If
capillary electrophoresis is coupled to laser-induced fluorescence, detection o f analytes
can be done following a fluorescence derivatization. Samples are loaded into a capillary

via hydrodynamic pressure. A charge is applied through the sample and the entire bulk
of the sample moves toward the charge. Molecules are separated based upon size to
charge (m/z) ratio. Molecules that are similarly charged to the bulk move more rapidly,
while molecules with an opposite charge of the bulk migrate more slowly. Neutralcharged molecules move at the same pace as the bulk. If two molecules have a similar
charge, larger molecules migrate more quickly. Relative carbonylation can be quantified
using wide peak analysis. A standard setup for capillary electrophoresis is shown in
Figure 6-2.
Microfluidic capillary electrophoresis uses the same principles as standard
capillary electrophoresis (Wang et al., 2012). Microfluidic capillary electrophoresis is
more attractive as a coupling technique than standard capillary electrophoresis because
the enrichment technique is also microfluidic-based. A typical setup for microfluidic
capillary electrophoresis is shown in Figure 6-3. The small volume eluted from the
microfluidic enrichment technique (15 pL) would be complementary to the sample
requirements for microfluidic capillary electrophoresis, as opposed to the higher
volumetric requirements for standard capillary electrophoresis (100 pL). The elution
volume is within the acceptable range for mass spectroscopy, which would be used to
identify the proteins that are eluted from the microdevice. With identification,
carbonylated proteins can be associated with different pathways and progress can be
made toward identifying potential carbonylated protein therapeutic targets. Also, in the
future, it may be possible to do an on-line coupling of the device to one of the techniques
mentioned above.
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Figure 6-1: Modular approach towards carbonylated protein biomarker discovery

Figure 6-2: Classic setup for capillary electrophoresis. After the sample is loaded into
the capillary using hydrodynamic pressure, a charge is applied to the sample.
Molecules migrate through the channel based upon size to charge (m/z) ratio. Neutral
charged molecules move at the same pace as the bulk solution. Larger molecules with
the opposite charge of the bulk solution migrate at a slower pace than smaller,
oppositely charged molecules. Larger molecules with the same charge as the bulk
solution migrate faster than smaller, similarly charged molecules.
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Figure 6-3: Instrumentation for microfluidic capillary electrophoresis

6.3
6.3.1

M ethod Im provem ents

Pulsed Flow vs. Continuous Flow
Biological samples, such as blood, cerebrospinal fluid, or plasma, are precious.

Other biological samples, such as urine or saliva, are more available and require less
invasive methods for obtaining them. Regardless of the availability of the sample or the
invasiveness of the method to collect it, the most optimal method for protein capture
(including both protein capture and time requirement) must be employed. In all the
studies described in this dissertation, a continuous flow injection was used, followed by
an incubation period. This procedure exposes the device to a large amount of proteins.
Use o f a pulsed flow may provide enhanced protein capture over a shorter time frame. A
flow rate duty cycle will allow proteins increased contact time during the loading cycle.
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As stated in Chapter 4, an increased contact time allows for more bonds to be formed. A
50 % duty cycle (five minutes on, five minutes off), may allow experiments completed in
40 minutes o f continuous injections to be completed in two cycles. In the first cycle,
5 pg of proteins (assuming optimal conditions determined in Chapter 4) would be
injected into the channel and then allowed to have contact time in a stationary flow field.
The second cycle, also 5 pg, would be injected to fill any capture areas not already
occupied by proteins from the first cycle. After 20 minutes, 10 pg of proteins would
have been exposed to the device. This mass amount is the near the upper limit of proteins
captured during the optimization process.
6.3.2

BioMEMS vs. BioNEMS
BioMEMS is an emerging technology for on-chip cell cultures. This technology

is a great platform for cell studies because the dimensions are on the same scale as cells,
as the average animal cell diameter is 10 pm. For protein work, however, the scale may
be too large. As shown in Figure 5-3 and discussed in Chapter 5, much of the space
within the microchip is not usable for protein enrichment. A viable alternative
technology is Biological Nano-Electromechanical Systems, or BioNEMS. Nano
electromechanical systems (NEMS) incorporate mechanical and electrical components on
the nanometer scale. BioNEMS is the use o f NEMS for biological applications, such as
the one discussed in this dissertation. These chips could be constructed using electronbeam lithography, or EBL, that can create structures on the order of sub-100 nm range
(Hao et al., 2010), more in line with the size o f proteins. EBL has been used on PMMA
substrates to form complex nanostructures (Gautsch et al., 2010). Therefore, moving the
enrichment technique from a microfluidic platform to a nanofluidic platform has merit.
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One issue that would need to be considered in this leap from micro to nano would
be overcoming the increased pressure drop. Pressure drop in microfluidic channels have
been studied by numerous groups (Fuerstman et al., 2007; Akbari et al., 2009; Vanapalli
et al., 2007). For a rectangular channel, the equation for pressure drop is given as:
afiQL
AP = -------.
WH3

_ ^ ,
Eq. 6-1
M

For any rectangular channel where the aspect ratio ( W/ H) is below 1, and the
Reynolds number is below 1000, Eq. 6-1 is accurate to within 0.26 %. The above
equation demonstrates the challenge that comes with the transition from micro to nano.
In order to have sufficient capture, the channel will either have to be longer than the
current format (L increases), shorter in width ( W decreases), or more shallow in depth
(H decreases). Any one o f these changes will increase the pressure drop. Therefore, a
successful transition to BioNEMS would require a design change toward higherthroughput capability.
One group has suggested a method o f microfluidic device design that would
minimize pressure drop (Yeom et al., 2009). They propose a figure-of-merit (FOM) that
optimizes surface area and volume o f the device so that the functionality of the device is
maximized while the pressure drop is minimized. The use of a FOM analysis on the
nanofluidic device may assist in the development of a system that is not overcome by the
pressure drop.
6.3.3

Modeling the Flux of Oxalyldihydrazide and Proteins
The current model ignores reactions during the injection flow. Knowledge of

mass transport through the chip would be beneficial. As seen in Figure 5-3, there are
many cells within the channel that are not capable of capturing oxalyldihydrazide or
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proteins. However, it is assumed that the oxalyldihydrazide is dispersed evenly through
the microchip, with an equal amount o f oxalyldihydrazide and proteins in each cell o f the
chip. Because oxalyldihydrazide is only captured on the cells that contact the surface of
the microchannel, the molecules traveling in the innermost cells must migrate toward the
wall. The flux could be determined in three dimensions from a series o f onecompartment models.
6.3.4

Modeling Concentration Changes throughout the Chip
In addition to flux changes, concentration changes throughout the chip can be

modeled with fluid dynamics software, such as COMSOL. The software modeling can
perform the flux calculations needed and generate a visual representation o f the
concentration changes inside the microchip. Figure 6-4 shows a representative example
o f the expected results from such modeling, showing the anticipated profiles at different
locations along the x-axis. Figure 6-5 shows the expected concentration profiles along
the x-axis.
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6.3.5

Modeling Protein Capture under Flowing Conditions
The model was designed to predict protein capture. When the number of proteins

captured was converted to a mass quantity, the mass was over an order of magnitude
below the experimentally determined values in Chapter 4. This difference implies that
the reactions that take place during the crosslinker loading and protein loading are not
insignificant. In fact, binding kinetics should be considered in future experiments, as
well as possible protein orientation inside the microchip.

APPENDIX

ADDITIONAL INFORMATION ON THE AMINO ACIDS
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The structures, abbreviations, chemical properties, and possible oxidative
modifications of the amino acids are given in this appendix. The pi and pKa values were
obtained from Carey (2011). The oxidative modifications that are possible are found in
Madian and Regnier (2010).

OH
CH
O

ALANINE (Ala, A)
-Group: Neutral, non
polar
-pi: 6.00
-pKa: N/A
-Oxidation modification:
None

N hf^ N H

ARGININE (Arg, R)
-Group: Basic, polar
-pi: 10.76
-pKa: 12.48
-Oxidation modification:
glutamic semialdehyde
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ASPARAGINE (Asn, N)
-Group: Neutral, polar
-pi: 5.41
-pKa: N/A
-Oxidation modification:
hydroxylation

ASPARTIC ACID (Asp, D)
-Group: Acidic, polar
-pi: 2.77
-pKa: 3.55
-Oxidation modifications:
hydroxylation

CYSTEINE (Cys, C)
-Group: Neutral, polar
-pi: 5.07
-pKa: N/A
-Oxidation modifications:
cysteic acid, sulfinic acid,
sulfenic acid,
hydroxynonenal (HNE)
Michael adduct

GLUTAMIC ACID (Glu, E)
-Group: Acidic, polar
-pi: 3.22
-pKa: 4.25
O -Oxidation modification:
None

2
O

GLUTAMINE {Gin, Q)
-Group: Neutral, polar
-pi: 5.65
-pKa: N/A
-Oxidation modification:
None

GLYCINE (Gly, G)
-Group: Neutral, non
polar
-pi: 5.97
-pKa: N/A
-Oxidation modification:
None

Ill

HISTIDINE (His, H)
-Group: Basic, polar
-pi: 7.59
-pKa: 6.00
-Oxidation modifications:
4-hydroxy glutamate,
asparagine, aspartate, 2oxo-histidine,
hydroxynonenal (HNE)
Michael adduct

OH
O

NH

OH

CH
CH

O

NH

OH
CH
O

ISOLEUCINE (lie, I)
-Group: Neutral, non
polar
-pi: 6.02
-pKa: N/A
-Oxidation modification:
None

LEUCINE (Leu, L)
-Group: Neutral, non
polar
-pi: 5.98
-pKa: N/A
-Oxidation modification:
hydroxyleucine

LYSINE (Lys, K)
-Group: Basic, polar
-pi: 9.74
-pIC,: 10.53
NH2 -Oxidation modifications:
aminoadipic semialdehyde,
Amadort adduct, 3deoxyglucosone adduct,
glyoxal adduct, methylglyoxal
adduct, hydroxylation,
hydroxynonenal (HNE)
Michael adduct,
malondialdehyde
METHIONINE (Met, M)
-Group: Neutral, non
polar
-Pi: 5.74

CH3 -PKa: N/A
-Oxidation modifications:
sulfoxide, sulfone

PHENYLALANINE (Phe, F)
-Group: Neutral, non
polar
-pi: 5.48
-pKa: N/A
-Oxidation modifications:
hydroxylation,
dihydroxyphenylalanine

PROLINE (Pro, P)
-Group: Neutral, nonpolar
-pi: 6.30
-pKa: N/A
-Oxidation modifications
hydroxylation, glutamic
semialdehyde,
pyroglutamic acid,
pyrrolidinone

OH

SERINE (Ser, S)
-Group: Neutral, polar
-pi: 5.68
-pKa: N/A
-Oxidation modification:
None

NH2

OH

CH
OH
NH'

THREONINE (Thr, T)
-Group: Neutral, polar
-pi: 5.60
-pKa: N/A
-Oxidation modification:
2-amino-3-oxo-butanoic
acid

TRYPTOPHAN (Trp, W)
-Group: Neutral, polar
-pi: 5.89
-pKa: N/A
-Oxidation modifications:
formylkynurenin,
kynurenin, 2,4,5,6,7
hydroxylation of
trytophan, oxolactone

'N '
H

'OH

TYROSINE (Tyr, Y)
-Group: Neutral, polar
-pi: 5.66
-pKa: N/A
-Oxidation modification:
hydroxylation

VALINE (Val, V)
-Group: Neutral, non
polar
-pi: 5.96
-pKa: N/A
-Oxidation modification:
None
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